HIPK4
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00429 | S126 | Sugiyama | DNM1L DLP1 DRP1 | EIRQEIENETERISGNNKGVsPEPIHLKIFSPNVVNLTLVD |
| O00571 | S591 | Sugiyama | DDX3X DBX DDX3 | LENMAyEHHyKGssRGRSKssRFsGGFGARDYRQssGAsss |
| O00571 | S594 | Sugiyama | DDX3X DBX DDX3 | MAyEHHyKGssRGRSKssRFsGGFGARDYRQssGAssssFs |
| O15037 | S291 | Sugiyama | KHNYN KIAA0323 | GWKELPGEEAWEREVALRPQsVGGGAREsAPLKGKALGKEE |
| O15160 | S258 | Sugiyama | POLR1C POLR1E | DITLLEPVEGEAAEELSRCFsPGVIEVQEVQGKKVARVANP |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O75128 | S1224 | Sugiyama | COBL KIAA0633 | PAIPPPPPPPSQALSAPRTAsRFstGtLSNTADARQALMDA |
| O75390 | S453 | Sugiyama | CS | LAQLIWSRALGFPLERPKSMsTEGLMKFVDSKSG_______ |
| O95155 | S79 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | NMtPAtsPIGASGVAHRsQssEGVssLsssPsNsLEtQsQs |
| O95816 | S208 | Sugiyama | BAG2 | IKLLEHSKGAGSKTLQQNAEsRFN_________________ |
| O95817 | S399 | Sugiyama | BAG3 BIS | GPsAVPssPKsVAtEERAAPsTAPAEAtPPKPGEAEAPPKH |
| P00558 | S415 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGGAsLELLEGKVLPGVDALsNI__________________ |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04637 | S9 | GPS6|EPSD | TP53 P53 | ____________MEEPQsDPsVEPPLsQEtFsDLWKLLPEN |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P06744 | S107 | Sugiyama | GPI | GEKINyTEGRAVLHVALRNRsNtPILVDGKDVMPEVNKVLD |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P14618 | S37 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | QLHAAMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRs |
| P14618 | S55 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | IDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMNVARLN |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P17174 | S85 | Sugiyama | GOT1 | NsLNHEyLPILGLAEFRsCAsRLALGDDsPALKEKRVGGVQ |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P17987 | S35 | Sugiyama | TCP1 CCT1 CCTA | EtIRsQNVMAAAsIANIVKssLGPVGLDKMLVDDIGDVTIT |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P23193 | T136 | Sugiyama | TCEA1 GTF2S TFIIS | RKDETNARDTyVsSFPRAPstsDsVRLKCREMLAAALRTGD |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P26373 | S109 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | KVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILFPR |
| P26641 | S286 | Sugiyama | EEF1G EF1G PRO1608 | CEQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVA |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27695 | S135 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | SHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGDEEHDQEG |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P35613 | S246 | Sugiyama | BSG UNQ6505/PRO21383 | VKssEHINEGEtAMLVCKSEsVPPVTDWAWyKITDSEDKAL |
| P35998 | S89 | Sugiyama | PSMC2 MSS1 | DTGLAPPALWDLAADKQTLQsEQPLQVARCTKIINADSEDP |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P49790 | S203 | Sugiyama | NUP153 | ttsGFssRAsDKDITVsKNtsLPPLWsPEAERsHsLsQHtA |
| P50454 | S138 | Sugiyama | SERPINH1 CBP1 CBP2 HSP47 SERPINH2 PIG14 | LSNSTARNVTWKLGsRLyGPssVsFADDFVRssKQHYNCEH |
| P51812 | S715 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | APHLVKGAMAAtysALNRNQsPVLEPVGRsTLAQRRGIKKI |
| P53396 | S656 | Sugiyama | ACLY | IGNTGGMLDNILASKLyRPGsVAyVSRsGGMsNELNNIISR |
| P53992 | S378 | Sugiyama | SEC24C KIAA0079 | TTNFLVKDQGNASPRYIRCTsyNIPCTSDMAKQAQVPLAAV |
| P54252 | S260 | Sugiyama | ATXN3 ATX3 MJD MJD1 SCA3 | IDMEDEEADLRRAIQLsMQGssRNIsQDMtQtsGTNLTSEE |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P61353 | S39 | Sugiyama | RPL27 | SGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVTAAMGK |
| P61769 | S31 | Sugiyama | B2M CDABP0092 HDCMA22P | ALLSLSGLEAIQRTPKIQVysRHPAENGKSNFLNCYVsGFH |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P62241 | S4 | Sugiyama | RPS8 OK/SW-cl.83 | _________________MGIsRDNWHKRRKTGGKRKPYHKK |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P78347 | S214 | Sugiyama | GTF2I BAP135 WBSCR6 | HVGGRVMVtDADRsILsPGGsCGPIKVKTEPTEDSGIsLEM |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00613 | S375 | Sugiyama | HSF1 HSTF1 | TDtEGRPPsPPPtstPEKCLsVACLDKNELSDHLDAMDSNL |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q08AD1 | S1313 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | sLNtGDNEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWE |
| Q12792 | S142 | Sugiyama | TWF1 PTK9 | FGTVKEDVSLHGYKKyLLsQssPAPLtAAEEELRQIKINEV |
| Q12792 | S143 | Sugiyama | TWF1 PTK9 | GTVKEDVSLHGYKKyLLsQssPAPLtAAEEELRQIKINEVQ |
| Q13247 | S303 | Sugiyama | SRSF6 SFRS6 SRP55 | ENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKRAT |
| Q13263 | T415 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LNAWTKSAEAFGKIVAERPGtNstGPAPMAPPRAPGPLSKQ |
| Q13263 | T418 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | WTKSAEAFGKIVAERPGtNstGPAPMAPPRAPGPLSKQGsG |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13283 | S250 | Sugiyama | G3BP1 G3BP | sssPAPADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGI |
| Q13283 | S256 | Sugiyama | G3BP1 G3BP | ADIAQtVQEDLRtFsWAsVtsKNLPPSGAVPVTGIPPHVVK |
| Q13573 | S224 | Sugiyama | SNW1 SKIIP SKIP | KDPMEPPRFKINKKIPRGPPsPPAPVMHsPsRKMTVKEQQE |
| Q14258 | S100 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | DLAREPPADVWtPPARAsAPsPNAQVACDHCLKEAAVKTCL |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14738 | S598 | Sugiyama | PPP2R5D | DVyTIKALEAHKRAEEFLTAsQEAL________________ |
| Q14974 | S12 | Sugiyama | KPNB1 NTF97 | _________MELITILEKtVsPDRLELEAAQKFLERAAVEN |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q15818 | S91 | Sugiyama | NPTX1 | TILSQKETIRELTAKLGRCEsQsTLDPGAGEARAGGGRKQP |
| Q16513 | S583 | Sugiyama | PKN2 PRK2 PRKCL2 | VTKLDFDLEPEPPPAPPRAssLGEIDEssELRVLDIPGQDs |
| Q3KQU3 | S366 | Sugiyama | MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 | GPQPDRTHPSAAVPVCPRsAsAsPLtPCSVTRSVHRCAPAG |
| Q6GYQ0 | S797 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | EtGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDM |
| Q7Z2W4 | T273 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | FFQGsQEFLASASAsAERsCtPsPDQIsHRAsLEDAPVDDL |
| Q7Z6Z7 | S2887 | Sugiyama | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | LEEAVGDTSAAGSSEQPRAGsstPGDAPPAVAEVQGRSDGs |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q86YP4 | S100 | Sugiyama | GATAD2A | DGPVDMRTSHSDMKSERRPPsPDVIVLsDNEQPssPRVNGL |
| Q8IWW6 | S240 | Sugiyama | ARHGAP12 | SSSsTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLP |
| Q8IWW6 | T231 | Sugiyama | ARHGAP12 | QDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELKI |
| Q8IWX8 | S823 | Sugiyama | CHERP DAN26 SCAF6 | KSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRLGEEN |
| Q8IWX8 | S828 | Sugiyama | CHERP DAN26 SCAF6 | GRRRRsRsRsPtPPssAGLGsNsAPPIPDSRLGEENKGHQM |
| Q8IWX8 | S830 | Sugiyama | CHERP DAN26 SCAF6 | RRRsRsRsPtPPssAGLGsNsAPPIPDSRLGEENKGHQMLV |
| Q8IWX8 | T819 | Sugiyama | CHERP DAN26 SCAF6 | RSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRL |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NE63 | S298 | Sugiyama | HIPK4 | LERRKYMLKSLDQIETVNGGsVASRLTFPDREALAEHADLK |
| Q8NE63 | S337 | Sugiyama | HIPK4 | LKSMVELIKRMLTWESHERIsPSAALRHPFVSMQQLRSAHE |
| Q8NE63 | S406 | Sugiyama | HIPK4 | AEDGTPYYCLAEEKEAAGMGsVAGssPFFREEKAPGMQRAI |
| Q8NE63 | S410 | Sugiyama | HIPK4 | TPYYCLAEEKEAAGMGsVAGssPFFREEKAPGMQRAIDQLD |
| Q8NE63 | S411 | Sugiyama | HIPK4 | PYYCLAEEKEAAGMGsVAGssPFFREEKAPGMQRAIDQLDD |
| Q8NE63 | S469 | Sugiyama | HIPK4 | AVSDMMVPLKAAItGHHVPDsGPEPILAFySSRLAGRHKAR |
| Q8NE63 | S522 | Sugiyama | HIPK4 | SNLIRLSQVSPEDDRPCRGSsWEEGEHLGAsAEPLAILQRD |
| Q8NE63 | S532 | Sugiyama | HIPK4 | PEDDRPCRGSsWEEGEHLGAsAEPLAILQRDEDGPNIDNMT |
| Q8NE63 | T462 | Sugiyama | HIPK4 | WGETCTNAVSDMMVPLKAAItGHHVPDsGPEPILAFySSRL |
| Q8NE63 | Y175 | Sugiyama | HIPK4 | KVIDFGSASIFSEVRYVKEPyIQSRFYRAPEILLGLPFCEK |
| Q8NE63 | Y478 | Sugiyama | HIPK4 | KAAItGHHVPDsGPEPILAFySSRLAGRHKARKPPAGSKSD |
| Q8TD19 | S855 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | FsEsEKDTLPyEELQGLKVAsEAPLEHKPQVEAssPRLNPA |
| Q96BY7 | S1395 | Sugiyama | ATG2B C14orf103 | ADMKPGAFQRRSKVDSSGRSsSRGPVLPEADQQMLRDLMSD |
| Q96JH7 | S747 | Sugiyama | VCPIP1 KIAA1850 VCIP135 | MQKRKTEKLKQEQKGQPRtVsPstIRDGPssAPAtPtKAPy |
| Q96JH7 | S756 | Sugiyama | VCPIP1 KIAA1850 VCIP135 | KQEQKGQPRtVsPstIRDGPssAPAtPtKAPysPtTSKEKK |
| Q96JH7 | T750 | Sugiyama | VCPIP1 KIAA1850 VCIP135 | RKTEKLKQEQKGQPRtVsPstIRDGPssAPAtPtKAPysPt |
| Q9BQ39 | S140 | Sugiyama | DDX50 | KSSDNKLEETLTREQKEGAFsNFPIsEEtIKLLKGRGVTYL |
| Q9BV68 | S34 | Sugiyama | RNF126 | HCCsVEIVPRLPDYICPRCEsGFIEELPEETRSTENGSAPS |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9H4A3 | S167 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | AVAGPAPSTVPSSTSKDRPVsQPsLVGsKEEPPPARsGsGG |
| Q9H6T3 | T491 | Sugiyama | RPAP3 | ATGTTSKKNssQDDLFPTsDtPRAKVLKIEEVsDTssLQPQ |
| Q9H788 | S159 | Sugiyama | SH2D4A PPP1R38 SH2A | NQQtKDIWKKVAEKEELEQGsRPAPTLEEEKIRSLSSSSRN |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9NR30 | S189 | Sugiyama | DDX21 | EEsNsEIEQEIPVEQKEGAFsNFPIsEEtIKLLKGRGVTFL |
| Q9NTJ3 | T44 | Sugiyama | SMC4 CAPC SMC4L1 | DGAssDAEPEPPsGRtEsPAtAAEtAsEELDNRSLEEILNS |
| Q9NUQ3 | S97 | Sugiyama | TXLNG CXorf15 ELRG LSR5 | KHSLEEDEGsDFItENRNLVsPAyCtQEsREEIPGGEARTD |
| Q9NYM9 | S9 | Sugiyama | BET1L GS15 | ____________MADWARAQsPGAVEEILDRENKRMADSLA |
| Q9UBP6 | S27 | Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UPQ0 | S192 | Sugiyama | LIMCH1 KIAA1102 | RSIRDsGyIDCWDsERsDsLsPPRHGRDDsFDsLDsFGsRs |
| Q9UQ35 | S1099 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sHsEsPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRG |
| Q9UQ35 | S1101 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEsPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEF |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2398 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ANLtsPRVPLsAyERVsGRtsPPLLDRARsRtPPsAPsQsR |
| Q9Y230 | S43 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | GAHSHIRGLGLDDALEPRQAsQGMVGQLAARRAAGVVLEMI |
| Q9Y5K6 | S458 | Sugiyama | CD2AP | ETEPVSKLKLDsEQLPLRPKsVDFDsLtVRtsKEtDVVNFD |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 2.174208e-08 | 7.663 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.861319e-07 | 6.730 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.334132e-06 | 5.632 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.867282e-05 | 4.104 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.012786e-04 | 3.696 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.404155e-04 | 3.619 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.453611e-04 | 3.610 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.944979e-04 | 3.306 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.944979e-04 | 3.306 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.944979e-04 | 3.306 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.352613e-04 | 3.271 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.517968e-04 | 3.345 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.949052e-04 | 3.404 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.056501e-04 | 3.296 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.729764e-04 | 3.172 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 9.346194e-04 | 3.029 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.420262e-03 | 2.848 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.592367e-03 | 2.798 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.713732e-03 | 2.766 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.001394e-03 | 2.699 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.001394e-03 | 2.699 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.058815e-03 | 2.686 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 2.509935e-03 | 2.600 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.470930e-03 | 2.607 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.509583e-03 | 2.600 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.655154e-03 | 2.576 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.657462e-03 | 2.576 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.870600e-03 | 2.542 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.912766e-03 | 2.536 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 3.105611e-03 | 2.508 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.091355e-03 | 2.388 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.515235e-03 | 2.345 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.504706e-03 | 2.346 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.674363e-03 | 2.246 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.674363e-03 | 2.246 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.633300e-03 | 2.249 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.706461e-03 | 2.244 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.934270e-03 | 2.227 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.921737e-03 | 2.160 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.627741e-03 | 2.118 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.593693e-03 | 2.120 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.627741e-03 | 2.118 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.063533e-03 | 2.093 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.082347e-03 | 2.042 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 9.528237e-03 | 2.021 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 9.528237e-03 | 2.021 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 9.528237e-03 | 2.021 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 9.224302e-03 | 2.035 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.006192e-02 | 1.997 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.076499e-02 | 1.968 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.056258e-02 | 1.976 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.076499e-02 | 1.968 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.093543e-02 | 1.961 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.232316e-02 | 1.909 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.204371e-02 | 1.919 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.300256e-02 | 1.886 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.263650e-02 | 1.898 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.299756e-02 | 1.886 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.396573e-02 | 1.855 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.444711e-02 | 1.840 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.520461e-02 | 1.818 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.561709e-02 | 1.806 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.589628e-02 | 1.799 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.703062e-02 | 1.769 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.794625e-02 | 1.746 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.756511e-02 | 1.755 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.826254e-02 | 1.738 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.826254e-02 | 1.738 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.884115e-02 | 1.725 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.895288e-02 | 1.722 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.911669e-02 | 1.719 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.018526e-02 | 1.695 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.144689e-02 | 1.669 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.136567e-02 | 1.670 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.121927e-02 | 1.673 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.247705e-02 | 1.648 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.275148e-02 | 1.643 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.450517e-02 | 1.611 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.327767e-02 | 1.633 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.450517e-02 | 1.611 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.604903e-02 | 1.584 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.626300e-02 | 1.581 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.532299e-02 | 1.596 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.626300e-02 | 1.581 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.632057e-02 | 1.580 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.729411e-02 | 1.564 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.784237e-02 | 1.555 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.854685e-02 | 1.544 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.854685e-02 | 1.544 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.974838e-02 | 1.527 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.813720e-02 | 1.551 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.017765e-02 | 1.520 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.031944e-02 | 1.518 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.079360e-02 | 1.512 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.213126e-02 | 1.493 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.354879e-02 | 1.474 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.433985e-02 | 1.464 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.213126e-02 | 1.493 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.556321e-02 | 1.449 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.683620e-02 | 1.434 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 4.049233e-02 | 1.393 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 4.049233e-02 | 1.393 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 4.049233e-02 | 1.393 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 4.049233e-02 | 1.393 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 4.049233e-02 | 1.393 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.873792e-02 | 1.412 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.126296e-02 | 1.384 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.232064e-02 | 1.373 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.367030e-02 | 1.360 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 4.367030e-02 | 1.360 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.361833e-02 | 1.271 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.361833e-02 | 1.271 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.015203e-02 | 1.300 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.254090e-02 | 1.280 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.091530e-02 | 1.293 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.838928e-02 | 1.315 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.200088e-02 | 1.284 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.838928e-02 | 1.315 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.361833e-02 | 1.271 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.295992e-02 | 1.276 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.015203e-02 | 1.300 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.015203e-02 | 1.300 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.015203e-02 | 1.300 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.200088e-02 | 1.284 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.376513e-02 | 1.269 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.663264e-02 | 1.247 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.741604e-02 | 1.241 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.991237e-02 | 1.000 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.991237e-02 | 1.000 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.991237e-02 | 1.000 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 9.991237e-02 | 1.000 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.991237e-02 | 1.000 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.726072e-02 | 1.172 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.726072e-02 | 1.172 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.726072e-02 | 1.172 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.726072e-02 | 1.172 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.898476e-01 | 0.722 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.898476e-01 | 0.722 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.898476e-01 | 0.722 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.898476e-01 | 0.722 | 0 | 0 |
| Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) | R-HSA-9036092 | 1.898476e-01 | 0.722 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.898476e-01 | 0.722 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 9.825899e-02 | 1.008 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 9.825899e-02 | 1.008 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.323757e-01 | 0.878 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.323757e-01 | 0.878 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.323757e-01 | 0.878 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.323757e-01 | 0.878 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.323757e-01 | 0.878 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.323757e-01 | 0.878 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.708013e-01 | 0.567 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.708013e-01 | 0.567 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.708013e-01 | 0.567 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.708013e-01 | 0.567 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.708013e-01 | 0.567 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.708013e-01 | 0.567 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.708013e-01 | 0.567 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 9.016944e-02 | 1.045 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 9.016944e-02 | 1.045 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.016944e-02 | 1.045 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 9.016944e-02 | 1.045 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.016944e-02 | 1.045 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.686792e-01 | 0.773 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.686792e-01 | 0.773 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.686792e-01 | 0.773 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.686792e-01 | 0.773 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.686792e-01 | 0.773 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 1.686792e-01 | 0.773 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.114445e-01 | 0.953 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.114445e-01 | 0.953 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.584243e-02 | 1.120 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.584243e-02 | 1.120 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.252572e-02 | 1.204 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 9.073743e-02 | 1.042 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 9.073743e-02 | 1.042 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 9.073743e-02 | 1.042 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.344182e-01 | 0.872 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.063925e-01 | 0.685 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.063925e-01 | 0.685 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.063925e-01 | 0.685 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.063925e-01 | 0.685 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 2.063925e-01 | 0.685 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.436702e-01 | 0.464 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.436702e-01 | 0.464 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.436702e-01 | 0.464 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.436702e-01 | 0.464 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.436702e-01 | 0.464 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.436702e-01 | 0.464 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.436702e-01 | 0.464 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.436702e-01 | 0.464 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.588525e-01 | 0.799 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.242838e-01 | 0.906 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.845086e-01 | 0.734 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.912394e-02 | 1.050 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.622353e-01 | 0.790 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.622353e-01 | 0.790 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.111525e-01 | 0.675 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 2.111525e-01 | 0.675 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.111525e-01 | 0.675 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 2.835885e-01 | 0.547 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 2.835885e-01 | 0.547 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.835885e-01 | 0.547 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.092611e-01 | 0.388 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.092611e-01 | 0.388 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.092611e-01 | 0.388 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.092611e-01 | 0.388 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.092611e-01 | 0.388 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.092611e-01 | 0.388 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.092611e-01 | 0.388 | 0 | 0 |
| Defective GSS causes GSS deficiency | R-HSA-5579006 | 4.092611e-01 | 0.388 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.092611e-01 | 0.388 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.424556e-01 | 0.846 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.385595e-01 | 0.622 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.385595e-01 | 0.622 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.356373e-02 | 1.197 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.221107e-01 | 0.492 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.221107e-01 | 0.492 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.221107e-01 | 0.492 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.221107e-01 | 0.492 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.665172e-01 | 0.574 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.403222e-02 | 1.131 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.255860e-01 | 0.647 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.117733e-01 | 0.674 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.600912e-01 | 0.444 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.600912e-01 | 0.444 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.600912e-01 | 0.444 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.600912e-01 | 0.444 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.600912e-01 | 0.444 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.683006e-01 | 0.329 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.683006e-01 | 0.329 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.683006e-01 | 0.329 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.683006e-01 | 0.329 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 4.683006e-01 | 0.329 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.683006e-01 | 0.329 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.500459e-01 | 0.824 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.177661e-01 | 0.929 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.972537e-01 | 0.401 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.637645e-01 | 0.786 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.694739e-01 | 0.569 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.866422e-01 | 0.729 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.517896e-01 | 0.454 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.854329e-01 | 0.732 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.610321e-01 | 0.583 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.096458e-01 | 0.509 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.409474e-01 | 0.467 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.801258e-01 | 0.420 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.801258e-01 | 0.420 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.333826e-01 | 0.363 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.333826e-01 | 0.363 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.333826e-01 | 0.363 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.333826e-01 | 0.363 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.333826e-01 | 0.363 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.333826e-01 | 0.363 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.214427e-01 | 0.283 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.214427e-01 | 0.283 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.214427e-01 | 0.283 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.214427e-01 | 0.283 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.300423e-01 | 0.481 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.300423e-01 | 0.481 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.979722e-01 | 0.703 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.979722e-01 | 0.703 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.572563e-01 | 0.590 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.881063e-01 | 0.411 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.881063e-01 | 0.411 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.683135e-01 | 0.329 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.683135e-01 | 0.329 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.711387e-01 | 0.430 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.358406e-01 | 0.361 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.747645e-01 | 0.426 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.342305e-01 | 0.476 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.342305e-01 | 0.476 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.045803e-01 | 0.689 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.019249e-01 | 0.299 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.019249e-01 | 0.299 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.019249e-01 | 0.299 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.019249e-01 | 0.299 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.019249e-01 | 0.299 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.019249e-01 | 0.299 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.019249e-01 | 0.299 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.019249e-01 | 0.299 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.692763e-01 | 0.245 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.692763e-01 | 0.245 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.692763e-01 | 0.245 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.692763e-01 | 0.245 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.692763e-01 | 0.245 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.692763e-01 | 0.245 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.692763e-01 | 0.245 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.692763e-01 | 0.245 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.117360e-01 | 0.385 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.117360e-01 | 0.385 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.117360e-01 | 0.385 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 2.854335e-01 | 0.544 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.275025e-01 | 0.369 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.484764e-01 | 0.348 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.341318e-01 | 0.272 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.341318e-01 | 0.272 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.192569e-01 | 0.496 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.729905e-01 | 0.325 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.154808e-01 | 0.288 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.154808e-01 | 0.288 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.026781e-01 | 0.299 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.026781e-01 | 0.299 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.846950e-01 | 0.315 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.846950e-01 | 0.315 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.846950e-01 | 0.315 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.806564e-01 | 0.318 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.025270e-01 | 0.299 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.025270e-01 | 0.299 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.245162e-01 | 0.280 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.245162e-01 | 0.280 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.406679e-01 | 0.267 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.406679e-01 | 0.267 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.123312e-01 | 0.213 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.123312e-01 | 0.213 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.123312e-01 | 0.213 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.123312e-01 | 0.213 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.094246e-01 | 0.293 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.650825e-01 | 0.248 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.941371e-01 | 0.226 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.941371e-01 | 0.226 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.941371e-01 | 0.226 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.941371e-01 | 0.226 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.941371e-01 | 0.226 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.653300e-01 | 0.248 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 5.886855e-01 | 0.230 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.685253e-01 | 0.245 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.114476e-01 | 0.214 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.218960e-01 | 0.206 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.186537e-01 | 0.209 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 6.197487e-01 | 0.208 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.333482e-01 | 0.198 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.913672e-01 | 0.718 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.134244e-02 | 1.147 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 1.637645e-01 | 0.786 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.078523e-01 | 0.682 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.473347e-01 | 0.262 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 3.028493e-01 | 0.519 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.368479e-01 | 0.360 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.464348e-01 | 0.460 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.178422e-01 | 0.662 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.905615e-01 | 0.720 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.299168e-01 | 0.638 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.299168e-01 | 0.638 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.269155e-01 | 0.896 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.870487e-01 | 0.312 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.069122e-01 | 0.971 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.248155e-01 | 0.372 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.966965e-02 | 1.047 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.284026e-01 | 0.641 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.588525e-01 | 0.799 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.269155e-01 | 0.896 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.881063e-01 | 0.411 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.284153e-01 | 0.891 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.284026e-01 | 0.641 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.284026e-01 | 0.641 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 9.073743e-02 | 1.042 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.517298e-01 | 0.454 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.322994e-01 | 0.634 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.117360e-01 | 0.385 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.259544e-01 | 0.203 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.356373e-02 | 1.197 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.356373e-02 | 1.197 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.948271e-01 | 0.530 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.694739e-01 | 0.569 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.994675e-01 | 0.700 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.229998e-01 | 0.491 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.895708e-01 | 0.310 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.245162e-01 | 0.280 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.650825e-01 | 0.248 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.233067e-01 | 0.490 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.928100e-01 | 0.307 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.578691e-01 | 0.446 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 6.229641e-02 | 1.206 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.826061e-01 | 0.738 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.600912e-01 | 0.444 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.972537e-01 | 0.401 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.227258e-01 | 0.652 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.195837e-01 | 0.495 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.683135e-01 | 0.329 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.890749e-01 | 0.230 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 9.073743e-02 | 1.042 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.826745e-01 | 0.738 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.434106e-01 | 0.843 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.689383e-01 | 0.245 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.350477e-02 | 1.134 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.659355e-01 | 0.437 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.104148e-01 | 0.957 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.104148e-01 | 0.957 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 3.233067e-01 | 0.490 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.972537e-01 | 0.401 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.972537e-01 | 0.401 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.333826e-01 | 0.363 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.275278e-01 | 0.643 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.019249e-01 | 0.299 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.577601e-01 | 0.339 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.729905e-01 | 0.325 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 5.406679e-01 | 0.267 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.030663e-01 | 0.987 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.732429e-01 | 0.761 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.269951e-01 | 0.370 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.446645e-01 | 0.611 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.003074e-01 | 0.522 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.119126e-01 | 0.385 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.242838e-01 | 0.906 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.356373e-02 | 1.197 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.091114e-01 | 0.388 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.067966e-01 | 0.217 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.610321e-01 | 0.583 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.666678e-01 | 0.331 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.666678e-01 | 0.331 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 4.950957e-01 | 0.305 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.879028e-01 | 0.411 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.161763e-01 | 0.665 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.708013e-01 | 0.567 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.114445e-01 | 0.953 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 9.073743e-02 | 1.042 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.350477e-02 | 1.134 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.600912e-01 | 0.444 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.683006e-01 | 0.329 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.358406e-01 | 0.361 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.747645e-01 | 0.426 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 5.692763e-01 | 0.245 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.692763e-01 | 0.245 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.026781e-01 | 0.299 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.650825e-01 | 0.248 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.652060e-01 | 0.332 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.641915e-01 | 0.578 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 2.313360e-01 | 0.636 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.580993e-01 | 0.588 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.650825e-01 | 0.248 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 6.333482e-01 | 0.198 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.498313e-01 | 0.602 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.481406e-01 | 0.349 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.481406e-01 | 0.349 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.878027e-01 | 0.411 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.127685e-02 | 1.147 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 9.751934e-02 | 1.011 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.725623e-02 | 1.059 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.479709e-01 | 0.606 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.326638e-01 | 0.364 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.515937e-01 | 0.258 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.252572e-02 | 1.204 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.382318e-01 | 0.471 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.912394e-02 | 1.050 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.236272e-01 | 0.281 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.374926e-01 | 0.270 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 6.186537e-01 | 0.209 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.974618e-02 | 1.001 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.583935e-01 | 0.253 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.581738e-01 | 0.253 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.543580e-01 | 0.256 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.229998e-01 | 0.491 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.585304e-01 | 0.587 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.252572e-02 | 1.204 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.613752e-01 | 0.336 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.435653e-01 | 0.353 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.317744e-01 | 0.635 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.686792e-01 | 0.773 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.344182e-01 | 0.872 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 1.424556e-01 | 0.846 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.221107e-01 | 0.492 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.333023e-02 | 1.198 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.096341e-01 | 0.960 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.096341e-01 | 0.960 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.096341e-01 | 0.960 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.096341e-01 | 0.960 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.619330e-01 | 0.791 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.708048e-01 | 0.567 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.858984e-01 | 0.731 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.001733e-01 | 0.699 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.801258e-01 | 0.420 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.154808e-01 | 0.288 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.648792e-01 | 0.248 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.870502e-01 | 0.231 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.218960e-01 | 0.206 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.218960e-01 | 0.206 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 9.427912e-02 | 1.026 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.559292e-01 | 0.341 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.301838e-01 | 0.481 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.502945e-01 | 0.823 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.128168e-01 | 0.948 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.368479e-01 | 0.360 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 4.729905e-01 | 0.325 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.479709e-01 | 0.606 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.888577e-01 | 0.539 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.637169e-01 | 0.786 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 8.546261e-02 | 1.068 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.333826e-01 | 0.363 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.661236e-01 | 0.331 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.111525e-01 | 0.675 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.019249e-01 | 0.299 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.325123e-01 | 0.274 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.700415e-01 | 0.432 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.770186e-01 | 0.557 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.620317e-01 | 0.441 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.498313e-01 | 0.602 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.183155e-01 | 0.378 | 0 | 0 |
| S Phase | R-HSA-69242 | 5.778103e-01 | 0.238 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.109352e-01 | 0.507 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.385995e-01 | 0.858 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.683804e-01 | 0.571 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.905263e-01 | 0.408 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.100377e-01 | 0.678 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.852238e-02 | 1.105 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.092611e-01 | 0.388 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.498313e-01 | 0.602 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.214427e-01 | 0.283 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 4.683135e-01 | 0.329 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.178422e-01 | 0.662 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.256061e-01 | 0.647 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.978968e-01 | 0.400 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 5.154808e-01 | 0.288 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.123312e-01 | 0.213 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.432554e-01 | 0.844 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.641679e-01 | 0.439 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.995095e-02 | 1.097 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.067966e-01 | 0.217 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.545752e-01 | 0.256 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.545752e-01 | 0.256 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.579668e-01 | 0.801 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.826745e-01 | 0.738 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.529277e-01 | 0.344 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.444797e-01 | 0.352 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.981034e-01 | 0.303 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.686792e-01 | 0.773 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.448720e-01 | 0.611 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.448720e-01 | 0.611 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 4.683006e-01 | 0.329 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.708048e-01 | 0.567 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.854329e-01 | 0.732 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.369591e-01 | 0.625 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.941371e-01 | 0.226 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.941371e-01 | 0.226 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.356373e-02 | 1.197 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.259544e-01 | 0.203 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.295164e-01 | 0.367 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.284026e-01 | 0.641 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.881063e-01 | 0.411 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.299168e-01 | 0.638 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.102818e-01 | 0.508 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.069122e-01 | 0.971 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.125243e-01 | 0.949 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.295164e-01 | 0.367 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.630883e-01 | 0.334 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.374926e-01 | 0.270 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.958021e-02 | 1.225 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.630883e-01 | 0.334 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.411182e-01 | 0.850 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.396340e-02 | 1.131 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.972785e-01 | 0.303 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 1.898476e-01 | 0.722 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 2.708013e-01 | 0.567 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.686792e-01 | 0.773 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.344182e-01 | 0.872 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.344182e-01 | 0.872 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.436702e-01 | 0.464 | 0 | 0 |
| TGFBR3 regulates activin signaling | R-HSA-9839406 | 3.436702e-01 | 0.464 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.242838e-01 | 0.906 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.448720e-01 | 0.611 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 9.837415e-02 | 1.007 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.835885e-01 | 0.547 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.221107e-01 | 0.492 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.221107e-01 | 0.492 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.216620e-01 | 0.915 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.665172e-01 | 0.574 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.120973e-01 | 0.950 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.600912e-01 | 0.444 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.683006e-01 | 0.329 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.483957e-01 | 0.605 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.744402e-01 | 0.758 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.744402e-01 | 0.758 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.894344e-01 | 0.538 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.409474e-01 | 0.467 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.214427e-01 | 0.283 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.214427e-01 | 0.283 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.572133e-01 | 0.804 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 4.081820e-01 | 0.389 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.683135e-01 | 0.329 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.683135e-01 | 0.329 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.683135e-01 | 0.329 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.358406e-01 | 0.361 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.358406e-01 | 0.361 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.347841e-01 | 0.362 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.692763e-01 | 0.245 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 5.692763e-01 | 0.245 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 5.692763e-01 | 0.245 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.692763e-01 | 0.245 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.123312e-01 | 0.213 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.293292e-01 | 0.276 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.941371e-01 | 0.226 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.259544e-01 | 0.203 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.789108e-01 | 0.320 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.096341e-01 | 0.960 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.564786e-01 | 0.591 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.112384e-01 | 0.214 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.724712e-02 | 1.112 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.724712e-02 | 1.112 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.253517e-01 | 0.488 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.333387e-02 | 1.030 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.716994e-01 | 0.566 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.978968e-01 | 0.400 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.972537e-01 | 0.401 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.637763e-01 | 0.579 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.315689e-01 | 0.274 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.923717e-01 | 0.227 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.326638e-01 | 0.364 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.883158e-01 | 0.411 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.637763e-01 | 0.579 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.637763e-01 | 0.579 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.863281e-01 | 0.413 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.853695e-01 | 0.233 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.216620e-01 | 0.915 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.864549e-01 | 0.413 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.560940e-01 | 0.341 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 6.006021e-01 | 0.221 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.801621e-01 | 0.319 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.974618e-02 | 1.001 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.720627e-01 | 0.764 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.434106e-01 | 0.843 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.852238e-02 | 1.105 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.262291e-01 | 0.899 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.932443e-01 | 0.533 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 5.886855e-01 | 0.230 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.318409e-01 | 0.199 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.666678e-01 | 0.331 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.360547e-02 | 1.133 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.737010e-01 | 0.427 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.427588e-01 | 0.845 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.517896e-01 | 0.454 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.173940e-01 | 0.498 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.773678e-01 | 0.423 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.458813e-01 | 0.263 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 2.134970e-01 | 0.671 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.443309e-01 | 0.352 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.479136e-01 | 0.459 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.932443e-01 | 0.533 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.096741e-01 | 0.509 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 9.016944e-02 | 1.045 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.427588e-01 | 0.845 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.221107e-01 | 0.492 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.133005e-02 | 1.147 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.683006e-01 | 0.329 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.071244e-01 | 0.390 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.280070e-02 | 1.202 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.000466e-01 | 0.699 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.154808e-01 | 0.288 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.154808e-01 | 0.288 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.081820e-01 | 0.389 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.081820e-01 | 0.389 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.326638e-01 | 0.364 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 9.016944e-02 | 1.045 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.835885e-01 | 0.547 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.387092e-01 | 0.858 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.055626e-01 | 0.515 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.694449e-01 | 0.570 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.095402e-01 | 0.509 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.262726e-01 | 0.486 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.104409e-01 | 0.214 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.173940e-01 | 0.498 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.117733e-01 | 0.674 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.117733e-01 | 0.674 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.083161e-01 | 0.681 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 4.081820e-01 | 0.389 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.895708e-01 | 0.310 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.206506e-01 | 0.376 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.255860e-01 | 0.647 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.201351e-01 | 0.284 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.197473e-01 | 0.284 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.958021e-02 | 1.225 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.867209e-02 | 1.163 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.841790e-01 | 0.315 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.385995e-01 | 0.858 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.164411e-01 | 0.210 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.197473e-01 | 0.284 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.216620e-01 | 0.915 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.601888e-01 | 0.337 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.708013e-01 | 0.567 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 1.427588e-01 | 0.845 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 1.622353e-01 | 0.790 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.193013e-02 | 1.143 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.216620e-01 | 0.915 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.170925e-01 | 0.931 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.255860e-01 | 0.647 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.948271e-01 | 0.530 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.948271e-01 | 0.530 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.683006e-01 | 0.329 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.683006e-01 | 0.329 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 2.939803e-01 | 0.532 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.801258e-01 | 0.420 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.214427e-01 | 0.283 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 3.881063e-01 | 0.411 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.055626e-01 | 0.515 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.227610e-01 | 0.652 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.917185e-01 | 0.407 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.019249e-01 | 0.299 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.019249e-01 | 0.299 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.950957e-01 | 0.305 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.201480e-01 | 0.377 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.096458e-01 | 0.509 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.014387e-01 | 0.521 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.114445e-01 | 0.953 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 5.890749e-01 | 0.230 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.344182e-01 | 0.872 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.448720e-01 | 0.611 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.966965e-02 | 1.047 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.113936e-01 | 0.953 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.498313e-01 | 0.602 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.154808e-01 | 0.288 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.941371e-01 | 0.226 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.870502e-01 | 0.231 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.059853e-01 | 0.686 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 3.233067e-01 | 0.490 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 3.198311e-01 | 0.495 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.932443e-01 | 0.533 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.622353e-01 | 0.790 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.835885e-01 | 0.547 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.092611e-01 | 0.388 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 6.442044e-02 | 1.191 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.037604e-01 | 0.691 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.683006e-01 | 0.329 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.214427e-01 | 0.283 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.214427e-01 | 0.283 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 3.195837e-01 | 0.495 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 4.683135e-01 | 0.329 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.347841e-01 | 0.362 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 5.692763e-01 | 0.245 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.123312e-01 | 0.213 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.123312e-01 | 0.213 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.123312e-01 | 0.213 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.886855e-01 | 0.230 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.158360e-01 | 0.211 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.674798e-02 | 1.062 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.069552e-01 | 0.513 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.763837e-01 | 0.239 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.708048e-01 | 0.567 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 3.972537e-01 | 0.401 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.120438e-01 | 0.674 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.747960e-01 | 0.426 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.130617e-01 | 0.947 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 6.186537e-01 | 0.209 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.747960e-01 | 0.426 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.037604e-01 | 0.691 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.666678e-01 | 0.331 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.686792e-01 | 0.773 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.221107e-01 | 0.492 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.215525e-01 | 0.915 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.600912e-01 | 0.444 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.122444e-01 | 0.385 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.019249e-01 | 0.299 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.019249e-01 | 0.299 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.019249e-01 | 0.299 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.019249e-01 | 0.299 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.692763e-01 | 0.245 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.692763e-01 | 0.245 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.692763e-01 | 0.245 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 5.692763e-01 | 0.245 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.692763e-01 | 0.245 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.886855e-01 | 0.230 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.788847e-01 | 0.237 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.045781e-01 | 0.981 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.403594e-01 | 0.619 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.329973e-01 | 0.199 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.123312e-01 | 0.213 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.053476e-01 | 0.977 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.194194e-01 | 0.208 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.562913e-01 | 0.448 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.114476e-01 | 0.214 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.218960e-01 | 0.206 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.434106e-01 | 0.843 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.648792e-01 | 0.248 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.341318e-01 | 0.272 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.423156e-01 | 0.192 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.435558e-01 | 0.191 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.445070e-01 | 0.191 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.481633e-01 | 0.188 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.481633e-01 | 0.188 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.481633e-01 | 0.188 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.481633e-01 | 0.188 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.481633e-01 | 0.188 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.481633e-01 | 0.188 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.510846e-01 | 0.186 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.510846e-01 | 0.186 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.510846e-01 | 0.186 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.510846e-01 | 0.186 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.510846e-01 | 0.186 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.510846e-01 | 0.186 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.510846e-01 | 0.186 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.510846e-01 | 0.186 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 6.510846e-01 | 0.186 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.510846e-01 | 0.186 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.510846e-01 | 0.186 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.510846e-01 | 0.186 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.510846e-01 | 0.186 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.543745e-01 | 0.184 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.543745e-01 | 0.184 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.543745e-01 | 0.184 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.550207e-01 | 0.184 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.558063e-01 | 0.183 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.578402e-01 | 0.182 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.624423e-01 | 0.179 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.624423e-01 | 0.179 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.624423e-01 | 0.179 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.634535e-01 | 0.178 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.644470e-01 | 0.178 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.644470e-01 | 0.178 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.729597e-01 | 0.172 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.729597e-01 | 0.172 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.729597e-01 | 0.172 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.729597e-01 | 0.172 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.741244e-01 | 0.171 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.745205e-01 | 0.171 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.745205e-01 | 0.171 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.745205e-01 | 0.171 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 6.745205e-01 | 0.171 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.745205e-01 | 0.171 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.745205e-01 | 0.171 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 6.745205e-01 | 0.171 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.791419e-01 | 0.168 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.859661e-01 | 0.164 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.859661e-01 | 0.164 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.859661e-01 | 0.164 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.859661e-01 | 0.164 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.859661e-01 | 0.164 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.859661e-01 | 0.164 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.859661e-01 | 0.164 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.859661e-01 | 0.164 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.861892e-01 | 0.164 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.910655e-01 | 0.160 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.937865e-01 | 0.159 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.937865e-01 | 0.159 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.937865e-01 | 0.159 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.939734e-01 | 0.159 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 6.963167e-01 | 0.157 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 6.963167e-01 | 0.157 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.963167e-01 | 0.157 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.963167e-01 | 0.157 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.963167e-01 | 0.157 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.963167e-01 | 0.157 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.963167e-01 | 0.157 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.964306e-01 | 0.157 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.964306e-01 | 0.157 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.967708e-01 | 0.157 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.030856e-01 | 0.153 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.064738e-01 | 0.151 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.090257e-01 | 0.149 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.121779e-01 | 0.147 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.121779e-01 | 0.147 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.121779e-01 | 0.147 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.122425e-01 | 0.147 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.122484e-01 | 0.147 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.126199e-01 | 0.147 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 7.153932e-01 | 0.145 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.173623e-01 | 0.144 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.173623e-01 | 0.144 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.173623e-01 | 0.144 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.173623e-01 | 0.144 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.173623e-01 | 0.144 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.173623e-01 | 0.144 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.173623e-01 | 0.144 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.173623e-01 | 0.144 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.173623e-01 | 0.144 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.173623e-01 | 0.144 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.173623e-01 | 0.144 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.173623e-01 | 0.144 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.173623e-01 | 0.144 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.173623e-01 | 0.144 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.182744e-01 | 0.144 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.182744e-01 | 0.144 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 7.182744e-01 | 0.144 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.182744e-01 | 0.144 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 7.182744e-01 | 0.144 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.182744e-01 | 0.144 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 7.182744e-01 | 0.144 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.182744e-01 | 0.144 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.182744e-01 | 0.144 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.200778e-01 | 0.143 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.200778e-01 | 0.143 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.213163e-01 | 0.142 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 7.242678e-01 | 0.140 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.292522e-01 | 0.137 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.297048e-01 | 0.137 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.297048e-01 | 0.137 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.297048e-01 | 0.137 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.388789e-01 | 0.131 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.388789e-01 | 0.131 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.388789e-01 | 0.131 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.388789e-01 | 0.131 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.388789e-01 | 0.131 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.388789e-01 | 0.131 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.395932e-01 | 0.131 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.398427e-01 | 0.131 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.426840e-01 | 0.129 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.426840e-01 | 0.129 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.456213e-01 | 0.127 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.456213e-01 | 0.127 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.456213e-01 | 0.127 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.456213e-01 | 0.127 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.456213e-01 | 0.127 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.456213e-01 | 0.127 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.456213e-01 | 0.127 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.456213e-01 | 0.127 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.456213e-01 | 0.127 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 7.456213e-01 | 0.127 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.463813e-01 | 0.127 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.463813e-01 | 0.127 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.463813e-01 | 0.127 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.472616e-01 | 0.127 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.507074e-01 | 0.125 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.514362e-01 | 0.124 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.554883e-01 | 0.122 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.568541e-01 | 0.121 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.568541e-01 | 0.121 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.581813e-01 | 0.120 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.622246e-01 | 0.118 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.688618e-01 | 0.114 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.704130e-01 | 0.113 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.710564e-01 | 0.113 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.710564e-01 | 0.113 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.710564e-01 | 0.113 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.710564e-01 | 0.113 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.710564e-01 | 0.113 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.710564e-01 | 0.113 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.710564e-01 | 0.113 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.710564e-01 | 0.113 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.710564e-01 | 0.113 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.710564e-01 | 0.113 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.710564e-01 | 0.113 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.710564e-01 | 0.113 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 7.735333e-01 | 0.112 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 7.749567e-01 | 0.111 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.762360e-01 | 0.110 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.762360e-01 | 0.110 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 7.762360e-01 | 0.110 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.762360e-01 | 0.110 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.764457e-01 | 0.110 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.772549e-01 | 0.109 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 7.772549e-01 | 0.109 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.772549e-01 | 0.109 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.772549e-01 | 0.109 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.805507e-01 | 0.108 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.833709e-01 | 0.106 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.914947e-01 | 0.102 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.914947e-01 | 0.102 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.914947e-01 | 0.102 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.930994e-01 | 0.101 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.930994e-01 | 0.101 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.930994e-01 | 0.101 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.930994e-01 | 0.101 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.930994e-01 | 0.101 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.939495e-01 | 0.100 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.939495e-01 | 0.100 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.939495e-01 | 0.100 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.939495e-01 | 0.100 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 7.939495e-01 | 0.100 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.939495e-01 | 0.100 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.021538e-01 | 0.096 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.049680e-01 | 0.094 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.075333e-01 | 0.093 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.075333e-01 | 0.093 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.075333e-01 | 0.093 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.088291e-01 | 0.092 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.088291e-01 | 0.092 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.088291e-01 | 0.092 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.088291e-01 | 0.092 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 8.093909e-01 | 0.092 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.093909e-01 | 0.092 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.094924e-01 | 0.092 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 8.109996e-01 | 0.091 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.145547e-01 | 0.089 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.145547e-01 | 0.089 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.145547e-01 | 0.089 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.145547e-01 | 0.089 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.145547e-01 | 0.089 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.145547e-01 | 0.089 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.145547e-01 | 0.089 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.145547e-01 | 0.089 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.145547e-01 | 0.089 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.177005e-01 | 0.087 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.177005e-01 | 0.087 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.177005e-01 | 0.087 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.187657e-01 | 0.087 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.188498e-01 | 0.087 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.216712e-01 | 0.085 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.257904e-01 | 0.083 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.294523e-01 | 0.081 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.297190e-01 | 0.081 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.323035e-01 | 0.080 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.331005e-01 | 0.079 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.331005e-01 | 0.079 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.331005e-01 | 0.079 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.331005e-01 | 0.079 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.331005e-01 | 0.079 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.331005e-01 | 0.079 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.331005e-01 | 0.079 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.331005e-01 | 0.079 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.331005e-01 | 0.079 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.331005e-01 | 0.079 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.366502e-01 | 0.077 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.371197e-01 | 0.077 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.371197e-01 | 0.077 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.371197e-01 | 0.077 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 8.371197e-01 | 0.077 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.388578e-01 | 0.076 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.389329e-01 | 0.076 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.396094e-01 | 0.076 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.398048e-01 | 0.076 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.398048e-01 | 0.076 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.410507e-01 | 0.075 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.417266e-01 | 0.075 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.433462e-01 | 0.074 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.497925e-01 | 0.071 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.497925e-01 | 0.071 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.497925e-01 | 0.071 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.497925e-01 | 0.071 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.497925e-01 | 0.071 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.497925e-01 | 0.071 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.497925e-01 | 0.071 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.497925e-01 | 0.071 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.497925e-01 | 0.071 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 8.497952e-01 | 0.071 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.497952e-01 | 0.071 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.497952e-01 | 0.071 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.497952e-01 | 0.071 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.497952e-01 | 0.071 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.517236e-01 | 0.070 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.517236e-01 | 0.070 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.585956e-01 | 0.066 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.606771e-01 | 0.065 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.615656e-01 | 0.065 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.615656e-01 | 0.065 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.615656e-01 | 0.065 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.615656e-01 | 0.065 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.615656e-01 | 0.065 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.617658e-01 | 0.065 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.617658e-01 | 0.065 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.617658e-01 | 0.065 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.637009e-01 | 0.064 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.648160e-01 | 0.063 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.648160e-01 | 0.063 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.648160e-01 | 0.063 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.648160e-01 | 0.063 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.648160e-01 | 0.063 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.648160e-01 | 0.063 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.648160e-01 | 0.063 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.648160e-01 | 0.063 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.648160e-01 | 0.063 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.648160e-01 | 0.063 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 8.648160e-01 | 0.063 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.648160e-01 | 0.063 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.648160e-01 | 0.063 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.648160e-01 | 0.063 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.648160e-01 | 0.063 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.648160e-01 | 0.063 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.712053e-01 | 0.060 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 8.712053e-01 | 0.060 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 8.712053e-01 | 0.060 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 8.712053e-01 | 0.060 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.712053e-01 | 0.060 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.712053e-01 | 0.060 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.724852e-01 | 0.059 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.724852e-01 | 0.059 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.724852e-01 | 0.059 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.724852e-01 | 0.059 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.724852e-01 | 0.059 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.752842e-01 | 0.058 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.752842e-01 | 0.058 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.752842e-01 | 0.058 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.752842e-01 | 0.058 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.770793e-01 | 0.057 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.783377e-01 | 0.056 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.783377e-01 | 0.056 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.783377e-01 | 0.056 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.783377e-01 | 0.056 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.783377e-01 | 0.056 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.783377e-01 | 0.056 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.783377e-01 | 0.056 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.800701e-01 | 0.055 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.800701e-01 | 0.055 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.809868e-01 | 0.055 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.813468e-01 | 0.055 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.826062e-01 | 0.054 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.826062e-01 | 0.054 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.826062e-01 | 0.054 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.826062e-01 | 0.054 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.826062e-01 | 0.054 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.830126e-01 | 0.054 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 8.830523e-01 | 0.054 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.830523e-01 | 0.054 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.830523e-01 | 0.054 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.830523e-01 | 0.054 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.833013e-01 | 0.054 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.880945e-01 | 0.052 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.883877e-01 | 0.051 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.884659e-01 | 0.051 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.903957e-01 | 0.050 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.905076e-01 | 0.050 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.905076e-01 | 0.050 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.905076e-01 | 0.050 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.905076e-01 | 0.050 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.905076e-01 | 0.050 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.905076e-01 | 0.050 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.905076e-01 | 0.050 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 8.905076e-01 | 0.050 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.905076e-01 | 0.050 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.931126e-01 | 0.049 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.961852e-01 | 0.048 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.961852e-01 | 0.048 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.961852e-01 | 0.048 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.973321e-01 | 0.047 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.999940e-01 | 0.046 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.999940e-01 | 0.046 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.006524e-01 | 0.045 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.006524e-01 | 0.045 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.014608e-01 | 0.045 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.014608e-01 | 0.045 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.014608e-01 | 0.045 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 9.014608e-01 | 0.045 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.014608e-01 | 0.045 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.014608e-01 | 0.045 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.014608e-01 | 0.045 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.016646e-01 | 0.045 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.034891e-01 | 0.044 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.038789e-01 | 0.044 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.048879e-01 | 0.043 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.082126e-01 | 0.042 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.086721e-01 | 0.042 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.086721e-01 | 0.042 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.103253e-01 | 0.041 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.107906e-01 | 0.041 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.113189e-01 | 0.040 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 9.113189e-01 | 0.040 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.113189e-01 | 0.040 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.113189e-01 | 0.040 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.113189e-01 | 0.040 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.113189e-01 | 0.040 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.113189e-01 | 0.040 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.123150e-01 | 0.040 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.125151e-01 | 0.040 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.141789e-01 | 0.039 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.153291e-01 | 0.038 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.157410e-01 | 0.038 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.157410e-01 | 0.038 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.160822e-01 | 0.038 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.161708e-01 | 0.038 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.167187e-01 | 0.038 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.175796e-01 | 0.037 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.198554e-01 | 0.036 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.201912e-01 | 0.036 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.201912e-01 | 0.036 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.201912e-01 | 0.036 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.201912e-01 | 0.036 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.201912e-01 | 0.036 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.201912e-01 | 0.036 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.205617e-01 | 0.036 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.213529e-01 | 0.036 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.229243e-01 | 0.035 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.229243e-01 | 0.035 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.241794e-01 | 0.034 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.270584e-01 | 0.033 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.272781e-01 | 0.033 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.272781e-01 | 0.033 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.281764e-01 | 0.032 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.281764e-01 | 0.032 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.281764e-01 | 0.032 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.281764e-01 | 0.032 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.281764e-01 | 0.032 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.286009e-01 | 0.032 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.313615e-01 | 0.031 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.313615e-01 | 0.031 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.313615e-01 | 0.031 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.317356e-01 | 0.031 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.317356e-01 | 0.031 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.321968e-01 | 0.030 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.321968e-01 | 0.030 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.334606e-01 | 0.030 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.350603e-01 | 0.029 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.353630e-01 | 0.029 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.353630e-01 | 0.029 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.353630e-01 | 0.029 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.353630e-01 | 0.029 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.353630e-01 | 0.029 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.373282e-01 | 0.028 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.383388e-01 | 0.028 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.383388e-01 | 0.028 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.394675e-01 | 0.027 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.402036e-01 | 0.027 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.404264e-01 | 0.027 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.409765e-01 | 0.026 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.418310e-01 | 0.026 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.418310e-01 | 0.026 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.418310e-01 | 0.026 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.418310e-01 | 0.026 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.418310e-01 | 0.026 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.418310e-01 | 0.026 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.425542e-01 | 0.026 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.425886e-01 | 0.026 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.453693e-01 | 0.024 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.453693e-01 | 0.024 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.470828e-01 | 0.024 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.476520e-01 | 0.023 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.476520e-01 | 0.023 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.476520e-01 | 0.023 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.476520e-01 | 0.023 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.476520e-01 | 0.023 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.477578e-01 | 0.023 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.496502e-01 | 0.022 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.499199e-01 | 0.022 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 9.499199e-01 | 0.022 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.499199e-01 | 0.022 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.509297e-01 | 0.022 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.510086e-01 | 0.022 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.510086e-01 | 0.022 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.515322e-01 | 0.022 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.528909e-01 | 0.021 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.528909e-01 | 0.021 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.528909e-01 | 0.021 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 9.532389e-01 | 0.021 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.537016e-01 | 0.021 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.538163e-01 | 0.021 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.541072e-01 | 0.020 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.541072e-01 | 0.020 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.546611e-01 | 0.020 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.546611e-01 | 0.020 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.548464e-01 | 0.020 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.554520e-01 | 0.020 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.566009e-01 | 0.019 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.576057e-01 | 0.019 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.576057e-01 | 0.019 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.576057e-01 | 0.019 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.576057e-01 | 0.019 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.576057e-01 | 0.019 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.576138e-01 | 0.019 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.579583e-01 | 0.019 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.579583e-01 | 0.019 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.579583e-01 | 0.019 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.579583e-01 | 0.019 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.579583e-01 | 0.019 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 9.580576e-01 | 0.019 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.596033e-01 | 0.018 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.607933e-01 | 0.017 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.612143e-01 | 0.017 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.614986e-01 | 0.017 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.618081e-01 | 0.017 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.618489e-01 | 0.017 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.618489e-01 | 0.017 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.618489e-01 | 0.017 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.618489e-01 | 0.017 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.618489e-01 | 0.017 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.618489e-01 | 0.017 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.618489e-01 | 0.017 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.618489e-01 | 0.017 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.618489e-01 | 0.017 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.621060e-01 | 0.017 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.635747e-01 | 0.016 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.641466e-01 | 0.016 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.641466e-01 | 0.016 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.643170e-01 | 0.016 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.647516e-01 | 0.016 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.647516e-01 | 0.016 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.647516e-01 | 0.016 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.647516e-01 | 0.016 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.656677e-01 | 0.015 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.656677e-01 | 0.015 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.656677e-01 | 0.015 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.661170e-01 | 0.015 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.661170e-01 | 0.015 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.668691e-01 | 0.015 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.677394e-01 | 0.014 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.677394e-01 | 0.014 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.677394e-01 | 0.014 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.679196e-01 | 0.014 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.683911e-01 | 0.014 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.683911e-01 | 0.014 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.684933e-01 | 0.014 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.684933e-01 | 0.014 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.684933e-01 | 0.014 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.686634e-01 | 0.014 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.690998e-01 | 0.014 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.691044e-01 | 0.014 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.691044e-01 | 0.014 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.691044e-01 | 0.014 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.691044e-01 | 0.014 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.691044e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.691044e-01 | 0.014 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.691044e-01 | 0.014 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.691044e-01 | 0.014 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.693956e-01 | 0.013 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.703386e-01 | 0.013 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.704825e-01 | 0.013 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.717391e-01 | 0.012 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.721972e-01 | 0.012 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.721972e-01 | 0.012 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.721972e-01 | 0.012 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.721972e-01 | 0.012 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.727862e-01 | 0.012 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.729817e-01 | 0.012 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.729999e-01 | 0.012 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.729999e-01 | 0.012 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.729999e-01 | 0.012 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.729999e-01 | 0.012 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.739118e-01 | 0.011 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.742162e-01 | 0.011 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.747210e-01 | 0.011 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.749806e-01 | 0.011 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.749806e-01 | 0.011 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.749806e-01 | 0.011 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.749806e-01 | 0.011 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.749806e-01 | 0.011 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.752926e-01 | 0.011 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.753093e-01 | 0.011 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.753093e-01 | 0.011 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.759253e-01 | 0.011 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.765314e-01 | 0.010 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.774271e-01 | 0.010 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.774271e-01 | 0.010 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.774856e-01 | 0.010 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.774856e-01 | 0.010 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.774856e-01 | 0.010 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.774856e-01 | 0.010 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.777904e-01 | 0.010 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.793685e-01 | 0.009 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.797398e-01 | 0.009 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.797785e-01 | 0.009 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.797785e-01 | 0.009 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.797785e-01 | 0.009 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.811476e-01 | 0.008 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.817685e-01 | 0.008 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.822064e-01 | 0.008 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.825946e-01 | 0.008 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.827636e-01 | 0.008 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.829490e-01 | 0.007 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.835941e-01 | 0.007 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.835941e-01 | 0.007 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.835941e-01 | 0.007 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.835941e-01 | 0.007 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.835941e-01 | 0.007 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.839279e-01 | 0.007 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.839279e-01 | 0.007 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.839279e-01 | 0.007 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.842700e-01 | 0.007 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.848546e-01 | 0.007 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.852266e-01 | 0.006 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.852266e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.852370e-01 | 0.006 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.852370e-01 | 0.006 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.856364e-01 | 0.006 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.856796e-01 | 0.006 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.857203e-01 | 0.006 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.857815e-01 | 0.006 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.858948e-01 | 0.006 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.866208e-01 | 0.006 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.866208e-01 | 0.006 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.867155e-01 | 0.006 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.867155e-01 | 0.006 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.867155e-01 | 0.006 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.867155e-01 | 0.006 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.867155e-01 | 0.006 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.867155e-01 | 0.006 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.867155e-01 | 0.006 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.867155e-01 | 0.006 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.867155e-01 | 0.006 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.868871e-01 | 0.006 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.868871e-01 | 0.006 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.874489e-01 | 0.005 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.880314e-01 | 0.005 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.880314e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.880460e-01 | 0.005 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.880460e-01 | 0.005 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.880460e-01 | 0.005 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.881167e-01 | 0.005 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.883315e-01 | 0.005 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.889415e-01 | 0.005 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.890781e-01 | 0.005 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.892433e-01 | 0.005 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.892433e-01 | 0.005 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.892433e-01 | 0.005 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.892433e-01 | 0.005 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.892441e-01 | 0.005 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.898346e-01 | 0.004 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.898346e-01 | 0.004 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.903208e-01 | 0.004 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.903208e-01 | 0.004 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.903208e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.903208e-01 | 0.004 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.903208e-01 | 0.004 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.909104e-01 | 0.004 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.909104e-01 | 0.004 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.911880e-01 | 0.004 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.912904e-01 | 0.004 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.916851e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.921629e-01 | 0.003 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.921629e-01 | 0.003 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.924131e-01 | 0.003 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.924411e-01 | 0.003 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.924411e-01 | 0.003 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.925136e-01 | 0.003 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.925470e-01 | 0.003 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.925470e-01 | 0.003 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.929480e-01 | 0.003 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.929480e-01 | 0.003 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.929480e-01 | 0.003 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.930272e-01 | 0.003 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.931087e-01 | 0.003 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.931611e-01 | 0.003 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.933207e-01 | 0.003 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.933207e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.935930e-01 | 0.003 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.936334e-01 | 0.003 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.936546e-01 | 0.003 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.936546e-01 | 0.003 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.937186e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.937186e-01 | 0.003 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.942754e-01 | 0.002 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.942904e-01 | 0.002 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.942904e-01 | 0.002 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.942904e-01 | 0.002 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.944683e-01 | 0.002 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.945666e-01 | 0.002 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.947838e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.947838e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.948625e-01 | 0.002 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.949824e-01 | 0.002 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.951897e-01 | 0.002 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.952411e-01 | 0.002 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.953674e-01 | 0.002 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.953773e-01 | 0.002 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.957238e-01 | 0.002 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.958405e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.958405e-01 | 0.002 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.958937e-01 | 0.002 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.959534e-01 | 0.002 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.960519e-01 | 0.002 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.961616e-01 | 0.002 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.962574e-01 | 0.002 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.962574e-01 | 0.002 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.962574e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.962574e-01 | 0.002 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.963510e-01 | 0.002 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.963767e-01 | 0.002 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.966325e-01 | 0.001 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.966325e-01 | 0.001 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.966325e-01 | 0.001 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.968997e-01 | 0.001 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.969700e-01 | 0.001 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.969700e-01 | 0.001 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.970372e-01 | 0.001 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.971437e-01 | 0.001 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.971902e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.972097e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.972124e-01 | 0.001 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.972737e-01 | 0.001 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.975092e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.975350e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.975470e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.975470e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.976089e-01 | 0.001 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.977169e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.977570e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.977570e-01 | 0.001 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.977929e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.977929e-01 | 0.001 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.978658e-01 | 0.001 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.980142e-01 | 0.001 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.980142e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.980142e-01 | 0.001 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.980209e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.980827e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.981434e-01 | 0.001 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.982435e-01 | 0.001 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.983286e-01 | 0.001 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.984641e-01 | 0.001 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.985029e-01 | 0.001 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.985181e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.985265e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.985265e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.985265e-01 | 0.001 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.986987e-01 | 0.001 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.987692e-01 | 0.001 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.987844e-01 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.988292e-01 | 0.001 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.988440e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.988454e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.988454e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.989255e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.989466e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.989650e-01 | 0.000 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.989650e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.990529e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.990529e-01 | 0.000 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.992328e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.992328e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.992795e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.992795e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.993495e-01 | 0.000 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.993731e-01 | 0.000 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.993750e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.993935e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.994413e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.994931e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.994974e-01 | 0.000 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.994974e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.994974e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.995106e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.995552e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.995667e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.995979e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.996340e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.996340e-01 | 0.000 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.996707e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.997000e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.997017e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997603e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.997849e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.998015e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.998267e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998430e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.998430e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.998744e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.998857e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.998972e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998972e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.999168e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999168e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.999273e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999559e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999612e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.999679e-01 | 0.000 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.999681e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999683e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999730e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.999754e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.999785e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999804e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999808e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999824e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999830e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999855e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999876e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999900e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999903e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999910e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999940e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999952e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999956e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999966e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999971e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999975e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999976e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999976e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999981e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999987e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999991e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999991e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999994e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999995e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999995e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999996e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999996e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999999e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999999e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 5.673774e-09 | 8.246 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.062741e-07 | 6.974 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.545812e-07 | 6.811 | 0 | 0 |
| M Phase | R-HSA-68886 | 5.648791e-06 | 5.248 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.966868e-06 | 5.224 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.010072e-05 | 4.996 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.396797e-05 | 4.855 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.508045e-05 | 4.601 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.039749e-05 | 4.517 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.867106e-05 | 4.413 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.417788e-05 | 4.355 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.603012e-05 | 4.337 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.326411e-05 | 4.135 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.634363e-05 | 4.117 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.326411e-05 | 4.135 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.864561e-05 | 4.104 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.062626e-05 | 4.043 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.263613e-04 | 3.898 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.557285e-04 | 3.808 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.557285e-04 | 3.808 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.470293e-04 | 3.833 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.671369e-04 | 3.777 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.658990e-04 | 3.780 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.420558e-04 | 3.848 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.808797e-04 | 3.743 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.119572e-04 | 3.674 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.119572e-04 | 3.674 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.306374e-04 | 3.637 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.058897e-04 | 3.514 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.248037e-04 | 3.488 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.423321e-04 | 3.466 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.552770e-04 | 3.449 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.986667e-04 | 3.399 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.073695e-04 | 3.390 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.288571e-04 | 3.368 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.666500e-04 | 3.331 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.397150e-04 | 3.268 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.629834e-04 | 3.064 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 9.326631e-04 | 3.030 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 9.326508e-04 | 3.030 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.002460e-03 | 2.999 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 9.667359e-04 | 3.015 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.213557e-03 | 2.916 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.194125e-03 | 2.923 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.289802e-03 | 2.889 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.459562e-03 | 2.836 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.776178e-03 | 2.751 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.887249e-03 | 2.724 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.521399e-03 | 2.598 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.579699e-03 | 2.588 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.017135e-03 | 2.520 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.130101e-03 | 2.504 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.247668e-03 | 2.488 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.555559e-03 | 2.449 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.675105e-03 | 2.435 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.885081e-03 | 2.411 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.885081e-03 | 2.411 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.144505e-03 | 2.383 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.255693e-03 | 2.371 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.392307e-03 | 2.357 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.861840e-03 | 2.313 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.231691e-03 | 2.281 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.314321e-03 | 2.275 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.353650e-03 | 2.271 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.373497e-03 | 2.270 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.823473e-03 | 2.235 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.679580e-03 | 2.246 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.852925e-03 | 2.233 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.347019e-03 | 2.197 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.595347e-03 | 2.181 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.868376e-03 | 2.163 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.490193e-03 | 2.188 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.004535e-03 | 2.155 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.123749e-03 | 2.147 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 7.419343e-03 | 2.130 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 8.353225e-03 | 2.078 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.353225e-03 | 2.078 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.256890e-03 | 2.083 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.762534e-03 | 2.057 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.728093e-03 | 2.059 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.411596e-03 | 2.075 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.416996e-03 | 2.075 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.416996e-03 | 2.075 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.256890e-03 | 2.083 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 8.762534e-03 | 2.057 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.107199e-03 | 2.041 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 9.355974e-03 | 2.029 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.619499e-03 | 2.017 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.619499e-03 | 2.017 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.099918e-02 | 1.959 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.099918e-02 | 1.959 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.099918e-02 | 1.959 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.099918e-02 | 1.959 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.099918e-02 | 1.959 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.099918e-02 | 1.959 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.099918e-02 | 1.959 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.091516e-02 | 1.962 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.137073e-02 | 1.944 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.180800e-02 | 1.928 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.180800e-02 | 1.928 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.283670e-02 | 1.892 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.295234e-02 | 1.888 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.297256e-02 | 1.887 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.297256e-02 | 1.887 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.329604e-02 | 1.876 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.351200e-02 | 1.869 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.534973e-02 | 1.814 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.471206e-02 | 1.832 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.497012e-02 | 1.825 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.534973e-02 | 1.814 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.471206e-02 | 1.832 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.662155e-02 | 1.779 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.777950e-02 | 1.750 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.816346e-02 | 1.741 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.816346e-02 | 1.741 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.816346e-02 | 1.741 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.816346e-02 | 1.741 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.014283e-02 | 1.696 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.850387e-02 | 1.733 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.896961e-02 | 1.722 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.990813e-02 | 1.701 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.892807e-02 | 1.723 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.861356e-02 | 1.730 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.162971e-02 | 1.665 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.199336e-02 | 1.658 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.340824e-02 | 1.631 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.351416e-02 | 1.629 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.385858e-02 | 1.622 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.409178e-02 | 1.618 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.561878e-02 | 1.591 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.589701e-02 | 1.587 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.660891e-02 | 1.575 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.600269e-02 | 1.585 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.589701e-02 | 1.587 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.589701e-02 | 1.587 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.561878e-02 | 1.591 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.589701e-02 | 1.587 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.715020e-02 | 1.566 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.803283e-02 | 1.552 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.819614e-02 | 1.550 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.926467e-02 | 1.534 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.031335e-02 | 1.518 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.031335e-02 | 1.518 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.031335e-02 | 1.518 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.120726e-02 | 1.506 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.130630e-02 | 1.504 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.447532e-02 | 1.462 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.606295e-02 | 1.443 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.550451e-02 | 1.450 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.424367e-02 | 1.465 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.684637e-02 | 1.434 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.297993e-02 | 1.482 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.447532e-02 | 1.462 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.316151e-02 | 1.479 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.573227e-02 | 1.447 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.424367e-02 | 1.465 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.290261e-02 | 1.483 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 3.737871e-02 | 1.427 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.737871e-02 | 1.427 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.752461e-02 | 1.426 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.818359e-02 | 1.418 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.818359e-02 | 1.418 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.818359e-02 | 1.418 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.818359e-02 | 1.418 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.818359e-02 | 1.418 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.818359e-02 | 1.418 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.969425e-02 | 1.401 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.970434e-02 | 1.401 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 3.973230e-02 | 1.401 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.973230e-02 | 1.401 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.999904e-02 | 1.398 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.470771e-02 | 1.350 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 4.585721e-02 | 1.339 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.585721e-02 | 1.339 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.585721e-02 | 1.339 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.120182e-02 | 1.385 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.079732e-02 | 1.389 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.470771e-02 | 1.350 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.024835e-02 | 1.395 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.585721e-02 | 1.339 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.543942e-02 | 1.343 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.455498e-02 | 1.351 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.426026e-02 | 1.354 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.470771e-02 | 1.350 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.725883e-02 | 1.326 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.791724e-02 | 1.320 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.837990e-02 | 1.315 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.838525e-02 | 1.315 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.949556e-02 | 1.305 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 5.902720e-02 | 1.229 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.626947e-02 | 1.250 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.626947e-02 | 1.250 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.626947e-02 | 1.250 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.432543e-02 | 1.265 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.432543e-02 | 1.265 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.932223e-02 | 1.227 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.963054e-02 | 1.225 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.963054e-02 | 1.225 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.582675e-02 | 1.253 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.582675e-02 | 1.253 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.721228e-02 | 1.243 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.129020e-02 | 1.290 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.432543e-02 | 1.265 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.963054e-02 | 1.225 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.421761e-02 | 1.266 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.660730e-02 | 1.247 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.582675e-02 | 1.253 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.963054e-02 | 1.225 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.177171e-02 | 1.286 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.473586e-02 | 1.262 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.626947e-02 | 1.250 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 5.121858e-02 | 1.291 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.678074e-02 | 1.246 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.166109e-02 | 1.210 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.357931e-02 | 1.197 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.454898e-02 | 1.190 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.490224e-02 | 1.188 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.545548e-02 | 1.184 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.598101e-02 | 1.181 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.756026e-02 | 1.170 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.909760e-02 | 1.161 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.922035e-02 | 1.160 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.944909e-02 | 1.158 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.955396e-02 | 1.158 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.985148e-02 | 1.156 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 7.515074e-02 | 1.124 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 7.515074e-02 | 1.124 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 7.515074e-02 | 1.124 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 8.084557e-02 | 1.092 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 8.084557e-02 | 1.092 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 8.084557e-02 | 1.092 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.311645e-02 | 1.080 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.360338e-02 | 1.133 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.904659e-02 | 1.102 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.904659e-02 | 1.102 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 8.402855e-02 | 1.076 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 8.402855e-02 | 1.076 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 8.325265e-02 | 1.080 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.097376e-02 | 1.149 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.890287e-02 | 1.103 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 8.084557e-02 | 1.092 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.437631e-02 | 1.074 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.260830e-02 | 1.083 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.919926e-02 | 1.101 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.240046e-02 | 1.084 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.410069e-02 | 1.130 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.309712e-02 | 1.080 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 8.311645e-02 | 1.080 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.415285e-02 | 1.075 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 8.084557e-02 | 1.092 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.360338e-02 | 1.133 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.325265e-02 | 1.080 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.721237e-02 | 1.112 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.443784e-02 | 1.073 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.752207e-02 | 1.058 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.835918e-02 | 1.054 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.845942e-02 | 1.053 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 8.875061e-02 | 1.052 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.875061e-02 | 1.052 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.875061e-02 | 1.052 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.899578e-02 | 1.051 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.899578e-02 | 1.051 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.300489e-02 | 1.031 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.462152e-02 | 1.024 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 9.546948e-02 | 1.020 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.587158e-02 | 1.018 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.587158e-02 | 1.018 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.880705e-02 | 1.005 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.007986e-01 | 0.997 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.009037e-01 | 0.996 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.025314e-01 | 0.989 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.446580e-01 | 0.840 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 2.089453e-01 | 0.680 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.089453e-01 | 0.680 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.089453e-01 | 0.680 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.046998e-01 | 0.980 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.046998e-01 | 0.980 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.046998e-01 | 0.980 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.684043e-01 | 0.571 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.684043e-01 | 0.571 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.684043e-01 | 0.571 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.684043e-01 | 0.571 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.684043e-01 | 0.571 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.684043e-01 | 0.571 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.684043e-01 | 0.571 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.684043e-01 | 0.571 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.684043e-01 | 0.571 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.684043e-01 | 0.571 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.684043e-01 | 0.571 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.684043e-01 | 0.571 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.684043e-01 | 0.571 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.684043e-01 | 0.571 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.684043e-01 | 0.571 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.684043e-01 | 0.571 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.143802e-01 | 0.942 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.143802e-01 | 0.942 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.844496e-01 | 0.734 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.844496e-01 | 0.734 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.844496e-01 | 0.734 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.844496e-01 | 0.734 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 1.844496e-01 | 0.734 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 1.844496e-01 | 0.734 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 3.233973e-01 | 0.490 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.233973e-01 | 0.490 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 3.233973e-01 | 0.490 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.233973e-01 | 0.490 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.233973e-01 | 0.490 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.233973e-01 | 0.490 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.233973e-01 | 0.490 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.314384e-01 | 0.881 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.126619e-01 | 0.672 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 2.126619e-01 | 0.672 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.126619e-01 | 0.672 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.126619e-01 | 0.672 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.126619e-01 | 0.672 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.493181e-01 | 0.826 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.209012e-01 | 0.918 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.679215e-01 | 0.775 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.412427e-01 | 0.618 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.412427e-01 | 0.618 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.412427e-01 | 0.618 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.412427e-01 | 0.618 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 3.742597e-01 | 0.427 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.742597e-01 | 0.427 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.742597e-01 | 0.427 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.742597e-01 | 0.427 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 3.742597e-01 | 0.427 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.742597e-01 | 0.427 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.871514e-01 | 0.728 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.484017e-01 | 0.829 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.484017e-01 | 0.829 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 1.484017e-01 | 0.829 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 2.699774e-01 | 0.569 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.192838e-01 | 0.923 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.192838e-01 | 0.923 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.069130e-01 | 0.684 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.069130e-01 | 0.684 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.304293e-01 | 0.885 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.304293e-01 | 0.885 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.054893e-01 | 0.977 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.271142e-01 | 0.644 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.986816e-01 | 0.525 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 4.213014e-01 | 0.375 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.213014e-01 | 0.375 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.240861e-01 | 0.906 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.240861e-01 | 0.906 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.240861e-01 | 0.906 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.540512e-01 | 0.812 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.540512e-01 | 0.812 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.664817e-01 | 0.779 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.094614e-01 | 0.679 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.094614e-01 | 0.679 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.271977e-01 | 0.485 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.684854e-01 | 0.571 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.684854e-01 | 0.571 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.684854e-01 | 0.571 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.684854e-01 | 0.571 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.249096e-01 | 0.903 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.422975e-01 | 0.616 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.422975e-01 | 0.616 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.894912e-01 | 0.538 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.553920e-01 | 0.449 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.553920e-01 | 0.449 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.553920e-01 | 0.449 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.553920e-01 | 0.449 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.553920e-01 | 0.449 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.648092e-01 | 0.333 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 4.648092e-01 | 0.333 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.648092e-01 | 0.333 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 4.648092e-01 | 0.333 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 4.648092e-01 | 0.333 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 4.648092e-01 | 0.333 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 4.648092e-01 | 0.333 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.648092e-01 | 0.333 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.648092e-01 | 0.333 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 4.648092e-01 | 0.333 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 4.648092e-01 | 0.333 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 4.648092e-01 | 0.333 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.197417e-01 | 0.658 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 1.497515e-01 | 0.825 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.591323e-01 | 0.586 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.001123e-01 | 0.699 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.344195e-01 | 0.872 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.761855e-01 | 0.559 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.761855e-01 | 0.559 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.481156e-01 | 0.605 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.317676e-01 | 0.479 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.626412e-01 | 0.581 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.150035e-01 | 0.668 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.496835e-01 | 0.603 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.496835e-01 | 0.603 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.496835e-01 | 0.603 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.496835e-01 | 0.603 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.529030e-01 | 0.452 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.103833e-01 | 0.387 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.103833e-01 | 0.387 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.103833e-01 | 0.387 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.050484e-01 | 0.297 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.050484e-01 | 0.297 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.050484e-01 | 0.297 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.050484e-01 | 0.297 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.050484e-01 | 0.297 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.050484e-01 | 0.297 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.050484e-01 | 0.297 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.050484e-01 | 0.297 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.374976e-01 | 0.624 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.739544e-01 | 0.427 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.072381e-01 | 0.513 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.072381e-01 | 0.513 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.607120e-01 | 0.584 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.141647e-01 | 0.669 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.370090e-01 | 0.360 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.370090e-01 | 0.360 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.948669e-01 | 0.404 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.948669e-01 | 0.404 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.948669e-01 | 0.404 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.375476e-01 | 0.472 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.292575e-01 | 0.482 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.807581e-01 | 0.419 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.428822e-01 | 0.465 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.428822e-01 | 0.465 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.360782e-01 | 0.360 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.593103e-01 | 0.445 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.761904e-01 | 0.322 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.087517e-01 | 0.389 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.957455e-01 | 0.305 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.149275e-01 | 0.288 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.149275e-01 | 0.288 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.149275e-01 | 0.288 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.001383e-01 | 0.301 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.032828e-01 | 0.298 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.652768e-01 | 0.782 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.835997e-01 | 0.416 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.240861e-01 | 0.906 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.329359e-01 | 0.876 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.131903e-01 | 0.384 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.131903e-01 | 0.384 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.101310e-01 | 0.678 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.072381e-01 | 0.513 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.441645e-01 | 0.841 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.656193e-01 | 0.781 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.656193e-01 | 0.781 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.131903e-01 | 0.384 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.107746e-01 | 0.508 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.792474e-01 | 0.747 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.196838e-01 | 0.922 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.149275e-01 | 0.288 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.493181e-01 | 0.826 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.094614e-01 | 0.679 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.529030e-01 | 0.452 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.884317e-01 | 0.725 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.285305e-01 | 0.483 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.562905e-01 | 0.341 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.149275e-01 | 0.288 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.684449e-01 | 0.329 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.197417e-01 | 0.658 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.072381e-01 | 0.513 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.656193e-01 | 0.781 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.292408e-01 | 0.367 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.106086e-01 | 0.508 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.107746e-01 | 0.508 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.370090e-01 | 0.360 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.792923e-01 | 0.746 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.106086e-01 | 0.508 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 2.626412e-01 | 0.581 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.807581e-01 | 0.419 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.871514e-01 | 0.728 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.684854e-01 | 0.571 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.632560e-01 | 0.440 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.375476e-01 | 0.472 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.169343e-01 | 0.932 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.169343e-01 | 0.932 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.529030e-01 | 0.452 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.126619e-01 | 0.672 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.126619e-01 | 0.672 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.699774e-01 | 0.569 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.922299e-01 | 0.534 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.739544e-01 | 0.427 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.457340e-01 | 0.461 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.629662e-01 | 0.334 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.761904e-01 | 0.322 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.126866e-01 | 0.290 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.486080e-01 | 0.604 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.085063e-01 | 0.511 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.080582e-01 | 0.966 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.001123e-01 | 0.699 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.415749e-01 | 0.849 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.496835e-01 | 0.603 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.517425e-01 | 0.345 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.649449e-01 | 0.783 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.746013e-01 | 0.561 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.072381e-01 | 0.513 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.133302e-01 | 0.504 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 4.711733e-01 | 0.327 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.131903e-01 | 0.384 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.586926e-01 | 0.799 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.314384e-01 | 0.881 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 2.126619e-01 | 0.672 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.271977e-01 | 0.485 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.894912e-01 | 0.538 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 3.553920e-01 | 0.449 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 4.648092e-01 | 0.333 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.285305e-01 | 0.483 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.780407e-01 | 0.749 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 2.986816e-01 | 0.525 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.562905e-01 | 0.341 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.208105e-01 | 0.376 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.208105e-01 | 0.376 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.722492e-01 | 0.326 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.192838e-01 | 0.923 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.553920e-01 | 0.449 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.922299e-01 | 0.534 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.993062e-01 | 0.700 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.935512e-01 | 0.713 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.154225e-01 | 0.667 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.020157e-01 | 0.520 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.529030e-01 | 0.452 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.850481e-01 | 0.545 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.301612e-01 | 0.886 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.213014e-01 | 0.375 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.476664e-01 | 0.606 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.271977e-01 | 0.485 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.155900e-01 | 0.381 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.680764e-01 | 0.434 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.328189e-01 | 0.364 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.072381e-01 | 0.513 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.387806e-01 | 0.358 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.942436e-01 | 0.404 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.434720e-01 | 0.843 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.795332e-01 | 0.421 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.045510e-01 | 0.297 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.370090e-01 | 0.360 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.291614e-01 | 0.889 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.382108e-01 | 0.623 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.493181e-01 | 0.826 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.699774e-01 | 0.569 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.282278e-01 | 0.484 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.666129e-01 | 0.436 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.562905e-01 | 0.341 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.139740e-01 | 0.383 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.301612e-01 | 0.886 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.742597e-01 | 0.427 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 3.742597e-01 | 0.427 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.742597e-01 | 0.427 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.476664e-01 | 0.606 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.422975e-01 | 0.616 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.648092e-01 | 0.333 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.725541e-01 | 0.565 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.811770e-01 | 0.419 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.738544e-01 | 0.427 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.069130e-01 | 0.684 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.355467e-01 | 0.868 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.086101e-01 | 0.964 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.271977e-01 | 0.485 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.387806e-01 | 0.358 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.387806e-01 | 0.358 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.387806e-01 | 0.358 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.387806e-01 | 0.358 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.470880e-01 | 0.607 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.658623e-01 | 0.332 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.658623e-01 | 0.332 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.949396e-01 | 0.305 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.894912e-01 | 0.538 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.632560e-01 | 0.440 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.576073e-01 | 0.340 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.370090e-01 | 0.360 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.949396e-01 | 0.305 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.149275e-01 | 0.288 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.267250e-01 | 0.370 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.767800e-01 | 0.753 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.069130e-01 | 0.684 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.446580e-01 | 0.840 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.089453e-01 | 0.680 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.089453e-01 | 0.680 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.089453e-01 | 0.680 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.046998e-01 | 0.980 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 2.684043e-01 | 0.571 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 2.684043e-01 | 0.571 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 2.684043e-01 | 0.571 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.844496e-01 | 0.734 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.233973e-01 | 0.490 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.412427e-01 | 0.618 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.412427e-01 | 0.618 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.271142e-01 | 0.644 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.213014e-01 | 0.375 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.213014e-01 | 0.375 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.935512e-01 | 0.713 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 3.271977e-01 | 0.485 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.059493e-01 | 0.686 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 4.648092e-01 | 0.333 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 4.648092e-01 | 0.333 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.050484e-01 | 0.297 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.050484e-01 | 0.297 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.370090e-01 | 0.360 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.155900e-01 | 0.381 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.562905e-01 | 0.341 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.668623e-01 | 0.331 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.338468e-01 | 0.363 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.878254e-01 | 0.312 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.863030e-01 | 0.413 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.980527e-01 | 0.526 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.663406e-01 | 0.779 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.686853e-01 | 0.571 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.347614e-01 | 0.629 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.238018e-01 | 0.373 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.234476e-01 | 0.373 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.524735e-01 | 0.344 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.464930e-01 | 0.608 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.320688e-01 | 0.634 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.370090e-01 | 0.360 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.620116e-01 | 0.335 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.582685e-01 | 0.446 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.314384e-01 | 0.881 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.943279e-01 | 0.306 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.194660e-01 | 0.496 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.040610e-01 | 0.690 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.756667e-01 | 0.560 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.572345e-01 | 0.447 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.274614e-01 | 0.895 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.582685e-01 | 0.446 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.103919e-01 | 0.508 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.209012e-01 | 0.918 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.684854e-01 | 0.571 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.317676e-01 | 0.479 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.882050e-01 | 0.311 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 4.562905e-01 | 0.341 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.126866e-01 | 0.290 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.837020e-01 | 0.315 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 3.548127e-01 | 0.450 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.682916e-01 | 0.329 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.072718e-01 | 0.512 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.069130e-01 | 0.684 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.935512e-01 | 0.713 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.282278e-01 | 0.484 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.499248e-01 | 0.347 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.825782e-01 | 0.417 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.213014e-01 | 0.375 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.553920e-01 | 0.449 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.862397e-01 | 0.730 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.222855e-01 | 0.913 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 4.629662e-01 | 0.334 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 5.126866e-01 | 0.290 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.463276e-01 | 0.350 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.488004e-01 | 0.457 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.488004e-01 | 0.457 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.488004e-01 | 0.457 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.761855e-01 | 0.559 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.934136e-01 | 0.533 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 4.629662e-01 | 0.334 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.360782e-01 | 0.360 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.979834e-01 | 0.703 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.126866e-01 | 0.290 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.972963e-01 | 0.401 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.722492e-01 | 0.326 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.823775e-01 | 0.418 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.339462e-01 | 0.873 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.484017e-01 | 0.829 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.089453e-01 | 0.680 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.301612e-01 | 0.886 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.233973e-01 | 0.490 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.412427e-01 | 0.618 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.412427e-01 | 0.618 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 3.742597e-01 | 0.427 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 3.742597e-01 | 0.427 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.271142e-01 | 0.644 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.213014e-01 | 0.375 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.924571e-01 | 0.716 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.924571e-01 | 0.716 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.648092e-01 | 0.333 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.050484e-01 | 0.297 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.884317e-01 | 0.725 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.584586e-01 | 0.800 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.807581e-01 | 0.419 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.304080e-01 | 0.638 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.882050e-01 | 0.311 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.840064e-01 | 0.416 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.169128e-01 | 0.380 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.151736e-01 | 0.382 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.249096e-01 | 0.903 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.127607e-01 | 0.290 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.211530e-01 | 0.493 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.756667e-01 | 0.560 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.387806e-01 | 0.358 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.496835e-01 | 0.603 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.155704e-01 | 0.381 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.223527e-01 | 0.492 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.295558e-01 | 0.888 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.068732e-01 | 0.684 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.710095e-01 | 0.567 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 1.568540e-01 | 0.805 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.233973e-01 | 0.490 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.699774e-01 | 0.569 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 2.986816e-01 | 0.525 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.684449e-01 | 0.329 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.355369e-01 | 0.361 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.933392e-01 | 0.714 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.590981e-01 | 0.338 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.315426e-01 | 0.635 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.206869e-01 | 0.494 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 2.684043e-01 | 0.571 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.412427e-01 | 0.618 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 2.699774e-01 | 0.569 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.213014e-01 | 0.375 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 4.648092e-01 | 0.333 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 3.831518e-01 | 0.417 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.481156e-01 | 0.605 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.103833e-01 | 0.387 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.050484e-01 | 0.297 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.955083e-01 | 0.305 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.169343e-01 | 0.932 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 4.370090e-01 | 0.360 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.328189e-01 | 0.364 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.304080e-01 | 0.638 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.484017e-01 | 0.829 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.836074e-01 | 0.316 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.087517e-01 | 0.389 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.844496e-01 | 0.734 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.412427e-01 | 0.618 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.213014e-01 | 0.375 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.271977e-01 | 0.485 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 4.648092e-01 | 0.333 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.103833e-01 | 0.387 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.050484e-01 | 0.297 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 5.050484e-01 | 0.297 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.789628e-01 | 0.747 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.244477e-01 | 0.649 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 5.105754e-01 | 0.292 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.629758e-01 | 0.788 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.648092e-01 | 0.333 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 2.197417e-01 | 0.658 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.629662e-01 | 0.334 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.709302e-01 | 0.431 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.126866e-01 | 0.290 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.648092e-01 | 0.333 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.050484e-01 | 0.297 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.470880e-01 | 0.607 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.836074e-01 | 0.316 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 3.553920e-01 | 0.449 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.455198e-01 | 0.351 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.329359e-01 | 0.876 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.997014e-01 | 0.700 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.585277e-01 | 0.800 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.431354e-01 | 0.844 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.699774e-01 | 0.569 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.831518e-01 | 0.417 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.274614e-01 | 0.895 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.934136e-01 | 0.533 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.032828e-01 | 0.298 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.107746e-01 | 0.508 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.230461e-01 | 0.652 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.164351e-01 | 0.287 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.164351e-01 | 0.287 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.164351e-01 | 0.287 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.164351e-01 | 0.287 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.318269e-01 | 0.274 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.324796e-01 | 0.274 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.324796e-01 | 0.274 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.324796e-01 | 0.274 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.324796e-01 | 0.274 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 5.324796e-01 | 0.274 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.330718e-01 | 0.273 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 5.335026e-01 | 0.273 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.337117e-01 | 0.273 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.337117e-01 | 0.273 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.349036e-01 | 0.272 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.349036e-01 | 0.272 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.363824e-01 | 0.271 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.363824e-01 | 0.271 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.363824e-01 | 0.271 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.363824e-01 | 0.271 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.363824e-01 | 0.271 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.363824e-01 | 0.271 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.363824e-01 | 0.271 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 5.422644e-01 | 0.266 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.422644e-01 | 0.266 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.422644e-01 | 0.266 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.422644e-01 | 0.266 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 5.422644e-01 | 0.266 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.422644e-01 | 0.266 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.422644e-01 | 0.266 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 5.422644e-01 | 0.266 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.422644e-01 | 0.266 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 5.422644e-01 | 0.266 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.422644e-01 | 0.266 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 5.422644e-01 | 0.266 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.430584e-01 | 0.265 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.434238e-01 | 0.265 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.520772e-01 | 0.258 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.520772e-01 | 0.258 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.571809e-01 | 0.254 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.592720e-01 | 0.252 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.592720e-01 | 0.252 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 5.592720e-01 | 0.252 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.592720e-01 | 0.252 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.592720e-01 | 0.252 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.592720e-01 | 0.252 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.598234e-01 | 0.252 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.598234e-01 | 0.252 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.637484e-01 | 0.249 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.637484e-01 | 0.249 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.637484e-01 | 0.249 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.637484e-01 | 0.249 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.648060e-01 | 0.248 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.658094e-01 | 0.247 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.700063e-01 | 0.244 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.738226e-01 | 0.241 | 0 | 0 |
| RSK activation | R-HSA-444257 | 5.766841e-01 | 0.239 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 5.766841e-01 | 0.239 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 5.766841e-01 | 0.239 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.766841e-01 | 0.239 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 5.766841e-01 | 0.239 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 5.766841e-01 | 0.239 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 5.766841e-01 | 0.239 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.766841e-01 | 0.239 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 5.766841e-01 | 0.239 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 5.766841e-01 | 0.239 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 5.766841e-01 | 0.239 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 5.766841e-01 | 0.239 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 5.766841e-01 | 0.239 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.766841e-01 | 0.239 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.766841e-01 | 0.239 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.813428e-01 | 0.236 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.813428e-01 | 0.236 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.813428e-01 | 0.236 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.813428e-01 | 0.236 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.813428e-01 | 0.236 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 5.813428e-01 | 0.236 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.813428e-01 | 0.236 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.813428e-01 | 0.236 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.813428e-01 | 0.236 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.813428e-01 | 0.236 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.819307e-01 | 0.235 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.874843e-01 | 0.231 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.874843e-01 | 0.231 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.874843e-01 | 0.231 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.874843e-01 | 0.231 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.874843e-01 | 0.231 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.895570e-01 | 0.229 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.895570e-01 | 0.229 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.905361e-01 | 0.229 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 5.932341e-01 | 0.227 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.938347e-01 | 0.226 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.938347e-01 | 0.226 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.025884e-01 | 0.220 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.025884e-01 | 0.220 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.025884e-01 | 0.220 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.084072e-01 | 0.216 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.084072e-01 | 0.216 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 6.085175e-01 | 0.216 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 6.085175e-01 | 0.216 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.085175e-01 | 0.216 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.085175e-01 | 0.216 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.085175e-01 | 0.216 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 6.085175e-01 | 0.216 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.085175e-01 | 0.216 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.085175e-01 | 0.216 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.085175e-01 | 0.216 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.085175e-01 | 0.216 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.085175e-01 | 0.216 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.085175e-01 | 0.216 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.085175e-01 | 0.216 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.085175e-01 | 0.216 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.085175e-01 | 0.216 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.085175e-01 | 0.216 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.085175e-01 | 0.216 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.085175e-01 | 0.216 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.085175e-01 | 0.216 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.085175e-01 | 0.216 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.085175e-01 | 0.216 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.109870e-01 | 0.214 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.116272e-01 | 0.214 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.116272e-01 | 0.214 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.128721e-01 | 0.213 | 0 | 0 |
| Kinesins | R-HSA-983189 | 6.129520e-01 | 0.213 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.176825e-01 | 0.209 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.176825e-01 | 0.209 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.210429e-01 | 0.207 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.210429e-01 | 0.207 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.210429e-01 | 0.207 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.230081e-01 | 0.206 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.230081e-01 | 0.206 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.233271e-01 | 0.205 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.256340e-01 | 0.204 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.272082e-01 | 0.203 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.332593e-01 | 0.198 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.365986e-01 | 0.196 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.371078e-01 | 0.196 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.371078e-01 | 0.196 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.379588e-01 | 0.195 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.379588e-01 | 0.195 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.379588e-01 | 0.195 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.379588e-01 | 0.195 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.379588e-01 | 0.195 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.379588e-01 | 0.195 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.379588e-01 | 0.195 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.379588e-01 | 0.195 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.379588e-01 | 0.195 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.379588e-01 | 0.195 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 6.379588e-01 | 0.195 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 6.379588e-01 | 0.195 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.379588e-01 | 0.195 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.379588e-01 | 0.195 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.379588e-01 | 0.195 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.379588e-01 | 0.195 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.396297e-01 | 0.194 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.409494e-01 | 0.193 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.426060e-01 | 0.192 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.426060e-01 | 0.192 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.426060e-01 | 0.192 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.426060e-01 | 0.192 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.426060e-01 | 0.192 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.426060e-01 | 0.192 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.502331e-01 | 0.187 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.502331e-01 | 0.187 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.526900e-01 | 0.185 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.526900e-01 | 0.185 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.604580e-01 | 0.180 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.613902e-01 | 0.180 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 6.613902e-01 | 0.180 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.613902e-01 | 0.180 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.613902e-01 | 0.180 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.621409e-01 | 0.179 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.621409e-01 | 0.179 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.621409e-01 | 0.179 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.633820e-01 | 0.178 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.636485e-01 | 0.178 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 6.651876e-01 | 0.177 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.651876e-01 | 0.177 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.651876e-01 | 0.177 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.651876e-01 | 0.177 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.651876e-01 | 0.177 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 6.651876e-01 | 0.177 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 6.651876e-01 | 0.177 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 6.651876e-01 | 0.177 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.651876e-01 | 0.177 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 6.651876e-01 | 0.177 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.677871e-01 | 0.175 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.737826e-01 | 0.171 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.737946e-01 | 0.171 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.750666e-01 | 0.171 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 6.793722e-01 | 0.168 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.814500e-01 | 0.167 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.834249e-01 | 0.165 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.836887e-01 | 0.165 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.888150e-01 | 0.162 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 6.903701e-01 | 0.161 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 6.903701e-01 | 0.161 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.903701e-01 | 0.161 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.903701e-01 | 0.161 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.903701e-01 | 0.161 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 6.903701e-01 | 0.161 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.903701e-01 | 0.161 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.903701e-01 | 0.161 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.903701e-01 | 0.161 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.903701e-01 | 0.161 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 6.903701e-01 | 0.161 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.903701e-01 | 0.161 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 6.950429e-01 | 0.158 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.962571e-01 | 0.157 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.965259e-01 | 0.157 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.965664e-01 | 0.157 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.965664e-01 | 0.157 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.965664e-01 | 0.157 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.965664e-01 | 0.157 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.965664e-01 | 0.157 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.010096e-01 | 0.154 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.010096e-01 | 0.154 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.070866e-01 | 0.151 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.101718e-01 | 0.149 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.101718e-01 | 0.149 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.101718e-01 | 0.149 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.129895e-01 | 0.147 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.129895e-01 | 0.147 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.129895e-01 | 0.147 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.136598e-01 | 0.147 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.136598e-01 | 0.147 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.136598e-01 | 0.147 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.136598e-01 | 0.147 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.136598e-01 | 0.147 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.136598e-01 | 0.147 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.136598e-01 | 0.147 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.136598e-01 | 0.147 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.136598e-01 | 0.147 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.136598e-01 | 0.147 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.136598e-01 | 0.147 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.136598e-01 | 0.147 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 7.136598e-01 | 0.147 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.136598e-01 | 0.147 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.136598e-01 | 0.147 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.188904e-01 | 0.143 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.190739e-01 | 0.143 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.190739e-01 | 0.143 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.233403e-01 | 0.141 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 7.233403e-01 | 0.141 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.243543e-01 | 0.140 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.279258e-01 | 0.138 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.279258e-01 | 0.138 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 7.286603e-01 | 0.137 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.286603e-01 | 0.137 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.286603e-01 | 0.137 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.286603e-01 | 0.137 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.351991e-01 | 0.134 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.351991e-01 | 0.134 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.351991e-01 | 0.134 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.351991e-01 | 0.134 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.351991e-01 | 0.134 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.351991e-01 | 0.134 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.351991e-01 | 0.134 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.351991e-01 | 0.134 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.360369e-01 | 0.133 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.360369e-01 | 0.133 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.379358e-01 | 0.132 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.406764e-01 | 0.130 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.435989e-01 | 0.129 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.435989e-01 | 0.129 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.435989e-01 | 0.129 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.435989e-01 | 0.129 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.435989e-01 | 0.129 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.463157e-01 | 0.127 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.476737e-01 | 0.126 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.482680e-01 | 0.126 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.482680e-01 | 0.126 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.551193e-01 | 0.122 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.551193e-01 | 0.122 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.551193e-01 | 0.122 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.551193e-01 | 0.122 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.551193e-01 | 0.122 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.551193e-01 | 0.122 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.551193e-01 | 0.122 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.551193e-01 | 0.122 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.551193e-01 | 0.122 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.551193e-01 | 0.122 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.567837e-01 | 0.121 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.578268e-01 | 0.120 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.578268e-01 | 0.120 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.578268e-01 | 0.120 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.578268e-01 | 0.120 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.593503e-01 | 0.120 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.593503e-01 | 0.120 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.594923e-01 | 0.119 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.600410e-01 | 0.119 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.600410e-01 | 0.119 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.625805e-01 | 0.118 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.639290e-01 | 0.117 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.663390e-01 | 0.116 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.666935e-01 | 0.115 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.669146e-01 | 0.115 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.704052e-01 | 0.113 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.713664e-01 | 0.113 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.730422e-01 | 0.112 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.735421e-01 | 0.112 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.735421e-01 | 0.112 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.735421e-01 | 0.112 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 7.735421e-01 | 0.112 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 7.735421e-01 | 0.112 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 7.735421e-01 | 0.112 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.735421e-01 | 0.112 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.735421e-01 | 0.112 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.735421e-01 | 0.112 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.735421e-01 | 0.112 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.735421e-01 | 0.112 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 7.735421e-01 | 0.112 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.752704e-01 | 0.111 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.752704e-01 | 0.111 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 7.780393e-01 | 0.109 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.822463e-01 | 0.107 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 7.842406e-01 | 0.106 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 7.842406e-01 | 0.106 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.861822e-01 | 0.104 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.905799e-01 | 0.102 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 7.905799e-01 | 0.102 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 7.905799e-01 | 0.102 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 7.905799e-01 | 0.102 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.905799e-01 | 0.102 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.905799e-01 | 0.102 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.905799e-01 | 0.102 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 7.905799e-01 | 0.102 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 7.905799e-01 | 0.102 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.905799e-01 | 0.102 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.905799e-01 | 0.102 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.905799e-01 | 0.102 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.926970e-01 | 0.101 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.926970e-01 | 0.101 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.926970e-01 | 0.101 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.926970e-01 | 0.101 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.927403e-01 | 0.101 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.945912e-01 | 0.100 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.945912e-01 | 0.100 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.953286e-01 | 0.099 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.027263e-01 | 0.095 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.027263e-01 | 0.095 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.027263e-01 | 0.095 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.027263e-01 | 0.095 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.029581e-01 | 0.095 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.063368e-01 | 0.093 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.063368e-01 | 0.093 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.063368e-01 | 0.093 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.063368e-01 | 0.093 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.063368e-01 | 0.093 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.063368e-01 | 0.093 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.063368e-01 | 0.093 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.067307e-01 | 0.093 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.080871e-01 | 0.093 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.080871e-01 | 0.093 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.080871e-01 | 0.093 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.080871e-01 | 0.093 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.080871e-01 | 0.093 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.080871e-01 | 0.093 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.123448e-01 | 0.090 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.123448e-01 | 0.090 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.160292e-01 | 0.088 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.168000e-01 | 0.088 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.191068e-01 | 0.087 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.191068e-01 | 0.087 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.191068e-01 | 0.087 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.208854e-01 | 0.086 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.209090e-01 | 0.086 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.209090e-01 | 0.086 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.209090e-01 | 0.086 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.209090e-01 | 0.086 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.209090e-01 | 0.086 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.209090e-01 | 0.086 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.209090e-01 | 0.086 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.209090e-01 | 0.086 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.209090e-01 | 0.086 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.215631e-01 | 0.085 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.234260e-01 | 0.084 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.295557e-01 | 0.081 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.295557e-01 | 0.081 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.295557e-01 | 0.081 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.295557e-01 | 0.081 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.295557e-01 | 0.081 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.295557e-01 | 0.081 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.295557e-01 | 0.081 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.303923e-01 | 0.081 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.303923e-01 | 0.081 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 8.343855e-01 | 0.079 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 8.343855e-01 | 0.079 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.343855e-01 | 0.079 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.343855e-01 | 0.079 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 8.343855e-01 | 0.079 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.343855e-01 | 0.079 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.343855e-01 | 0.079 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.343855e-01 | 0.079 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.343855e-01 | 0.079 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.343855e-01 | 0.079 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.364165e-01 | 0.078 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.364165e-01 | 0.078 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.374973e-01 | 0.077 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.376872e-01 | 0.077 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.384117e-01 | 0.077 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.388438e-01 | 0.076 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.394573e-01 | 0.076 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.394573e-01 | 0.076 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.394573e-01 | 0.076 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.468487e-01 | 0.072 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.468487e-01 | 0.072 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.468487e-01 | 0.072 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.468487e-01 | 0.072 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.468487e-01 | 0.072 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.468487e-01 | 0.072 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 8.468487e-01 | 0.072 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.468487e-01 | 0.072 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.468487e-01 | 0.072 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.469288e-01 | 0.072 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.469288e-01 | 0.072 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.469288e-01 | 0.072 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.479499e-01 | 0.072 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.482344e-01 | 0.071 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.488348e-01 | 0.071 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.488348e-01 | 0.071 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.539000e-01 | 0.069 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.546590e-01 | 0.068 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.575872e-01 | 0.067 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.583746e-01 | 0.066 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.583746e-01 | 0.066 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.583746e-01 | 0.066 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.583746e-01 | 0.066 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.583746e-01 | 0.066 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.583746e-01 | 0.066 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.620457e-01 | 0.064 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.620457e-01 | 0.064 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.622786e-01 | 0.064 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.638637e-01 | 0.064 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.641055e-01 | 0.063 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.641055e-01 | 0.063 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.643632e-01 | 0.063 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.661079e-01 | 0.062 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.669473e-01 | 0.062 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.687203e-01 | 0.061 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.690338e-01 | 0.061 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.690338e-01 | 0.061 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.690338e-01 | 0.061 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.690338e-01 | 0.061 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.691006e-01 | 0.061 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.691006e-01 | 0.061 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.703663e-01 | 0.060 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.740478e-01 | 0.058 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.740478e-01 | 0.058 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.754584e-01 | 0.058 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.758349e-01 | 0.058 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.758349e-01 | 0.058 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.788913e-01 | 0.056 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.788913e-01 | 0.056 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.788913e-01 | 0.056 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.788913e-01 | 0.056 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.788913e-01 | 0.056 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 8.788913e-01 | 0.056 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.788913e-01 | 0.056 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.788913e-01 | 0.056 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.797261e-01 | 0.056 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.815516e-01 | 0.055 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.815516e-01 | 0.055 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.835235e-01 | 0.054 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.848476e-01 | 0.053 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 8.880074e-01 | 0.052 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.880074e-01 | 0.052 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 8.880074e-01 | 0.052 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.880074e-01 | 0.052 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.880074e-01 | 0.052 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.886400e-01 | 0.051 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 8.888982e-01 | 0.051 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.942277e-01 | 0.049 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.946459e-01 | 0.048 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.953331e-01 | 0.048 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.953331e-01 | 0.048 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.953331e-01 | 0.048 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.953331e-01 | 0.048 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.964378e-01 | 0.047 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.964378e-01 | 0.047 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.964378e-01 | 0.047 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.964378e-01 | 0.047 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.964378e-01 | 0.047 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.980653e-01 | 0.047 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.992791e-01 | 0.046 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.992791e-01 | 0.046 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.997921e-01 | 0.046 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.998928e-01 | 0.046 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.016502e-01 | 0.045 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.016502e-01 | 0.045 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.016502e-01 | 0.045 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.016852e-01 | 0.045 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.029347e-01 | 0.044 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.037087e-01 | 0.044 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.042341e-01 | 0.044 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.042341e-01 | 0.044 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.042341e-01 | 0.044 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.042341e-01 | 0.044 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.042341e-01 | 0.044 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.050912e-01 | 0.043 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.101354e-01 | 0.041 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.101354e-01 | 0.041 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.101354e-01 | 0.041 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.101354e-01 | 0.041 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.114439e-01 | 0.040 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.114439e-01 | 0.040 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.114439e-01 | 0.040 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.114439e-01 | 0.040 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.114439e-01 | 0.040 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.114439e-01 | 0.040 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.114439e-01 | 0.040 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.114439e-01 | 0.040 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.114439e-01 | 0.040 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.120599e-01 | 0.040 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.132301e-01 | 0.039 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.132301e-01 | 0.039 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.132301e-01 | 0.039 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.143704e-01 | 0.039 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.149351e-01 | 0.039 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.161744e-01 | 0.038 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.181113e-01 | 0.037 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.181113e-01 | 0.037 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.181113e-01 | 0.037 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.181113e-01 | 0.037 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.185282e-01 | 0.037 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.185282e-01 | 0.037 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.185282e-01 | 0.037 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.185282e-01 | 0.037 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.235209e-01 | 0.035 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.235209e-01 | 0.035 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.242771e-01 | 0.034 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.242771e-01 | 0.034 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.242771e-01 | 0.034 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.242771e-01 | 0.034 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.242771e-01 | 0.034 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.242771e-01 | 0.034 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.242771e-01 | 0.034 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.242771e-01 | 0.034 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.254462e-01 | 0.034 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.257111e-01 | 0.034 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.269820e-01 | 0.033 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.279654e-01 | 0.032 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.282241e-01 | 0.032 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.299789e-01 | 0.032 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.299789e-01 | 0.032 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.309639e-01 | 0.031 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.319725e-01 | 0.031 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.326530e-01 | 0.030 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.326530e-01 | 0.030 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.337665e-01 | 0.030 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.352518e-01 | 0.029 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.352518e-01 | 0.029 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.352518e-01 | 0.029 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.368223e-01 | 0.028 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.368223e-01 | 0.028 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.374301e-01 | 0.028 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.395698e-01 | 0.027 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.401278e-01 | 0.027 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.401278e-01 | 0.027 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.401278e-01 | 0.027 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.401278e-01 | 0.027 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.401278e-01 | 0.027 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.424917e-01 | 0.026 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.443236e-01 | 0.025 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.444372e-01 | 0.025 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.444372e-01 | 0.025 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.446370e-01 | 0.025 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.446370e-01 | 0.025 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.446370e-01 | 0.025 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.446370e-01 | 0.025 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.446370e-01 | 0.025 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.486892e-01 | 0.023 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.488068e-01 | 0.023 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.488068e-01 | 0.023 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.488068e-01 | 0.023 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.488655e-01 | 0.023 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.511732e-01 | 0.022 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.511732e-01 | 0.022 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.515493e-01 | 0.022 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.523980e-01 | 0.021 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 9.526627e-01 | 0.021 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.541241e-01 | 0.020 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.542415e-01 | 0.020 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.548120e-01 | 0.020 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.562284e-01 | 0.019 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.562284e-01 | 0.019 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.568283e-01 | 0.019 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.570378e-01 | 0.019 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.571670e-01 | 0.019 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.571670e-01 | 0.019 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.595258e-01 | 0.018 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.595258e-01 | 0.018 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.595258e-01 | 0.018 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.595258e-01 | 0.018 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.595258e-01 | 0.018 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.595258e-01 | 0.018 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.598337e-01 | 0.018 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.602340e-01 | 0.018 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.625749e-01 | 0.017 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.625749e-01 | 0.017 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.625749e-01 | 0.017 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.637453e-01 | 0.016 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.637453e-01 | 0.016 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.647398e-01 | 0.016 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.647398e-01 | 0.016 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.647671e-01 | 0.016 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.653945e-01 | 0.015 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.653945e-01 | 0.015 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.653945e-01 | 0.015 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.653945e-01 | 0.015 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.654076e-01 | 0.015 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.670100e-01 | 0.015 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.672238e-01 | 0.014 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.680018e-01 | 0.014 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.680018e-01 | 0.014 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.680018e-01 | 0.014 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.680018e-01 | 0.014 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.680018e-01 | 0.014 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.680018e-01 | 0.014 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.680018e-01 | 0.014 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.691151e-01 | 0.014 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.704129e-01 | 0.013 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.704129e-01 | 0.013 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.704129e-01 | 0.013 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.704129e-01 | 0.013 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.704129e-01 | 0.013 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.705925e-01 | 0.013 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.705925e-01 | 0.013 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.710904e-01 | 0.013 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.710904e-01 | 0.013 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.746818e-01 | 0.011 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.746818e-01 | 0.011 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.747039e-01 | 0.011 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.747039e-01 | 0.011 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.747039e-01 | 0.011 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.747039e-01 | 0.011 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.747039e-01 | 0.011 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.763118e-01 | 0.010 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.766103e-01 | 0.010 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.766103e-01 | 0.010 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.783731e-01 | 0.009 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.783731e-01 | 0.009 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.783731e-01 | 0.009 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.785580e-01 | 0.009 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.787510e-01 | 0.009 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.788560e-01 | 0.009 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.794789e-01 | 0.009 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.806510e-01 | 0.008 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.814111e-01 | 0.008 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.815104e-01 | 0.008 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.828389e-01 | 0.008 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.829042e-01 | 0.007 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.829042e-01 | 0.007 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.829042e-01 | 0.007 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.829042e-01 | 0.007 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.829042e-01 | 0.007 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.831725e-01 | 0.007 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.831725e-01 | 0.007 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.831725e-01 | 0.007 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 9.841930e-01 | 0.007 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.841930e-01 | 0.007 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.841930e-01 | 0.007 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.849109e-01 | 0.007 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.851902e-01 | 0.006 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.852338e-01 | 0.006 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.853846e-01 | 0.006 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.853846e-01 | 0.006 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.861331e-01 | 0.006 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.870649e-01 | 0.006 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.872601e-01 | 0.006 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.877166e-01 | 0.005 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.884476e-01 | 0.005 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.884476e-01 | 0.005 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.884511e-01 | 0.005 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.891432e-01 | 0.005 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.891432e-01 | 0.005 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.892707e-01 | 0.005 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.901242e-01 | 0.004 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.901242e-01 | 0.004 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.907970e-01 | 0.004 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.907970e-01 | 0.004 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.908690e-01 | 0.004 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.912970e-01 | 0.004 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.914318e-01 | 0.004 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.915577e-01 | 0.004 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.917636e-01 | 0.004 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.925287e-01 | 0.003 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.933276e-01 | 0.003 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.934108e-01 | 0.003 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.934599e-01 | 0.003 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.935714e-01 | 0.003 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.936628e-01 | 0.003 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.938310e-01 | 0.003 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.938310e-01 | 0.003 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.946910e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.947267e-01 | 0.002 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.948824e-01 | 0.002 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.948978e-01 | 0.002 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.953777e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.954925e-01 | 0.002 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.958076e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.958326e-01 | 0.002 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.959769e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.962472e-01 | 0.002 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.962472e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.962472e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.968872e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.971851e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.971851e-01 | 0.001 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.972368e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.973976e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.973976e-01 | 0.001 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.976039e-01 | 0.001 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.977757e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.977913e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.978551e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.979437e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.979437e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.979437e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.980989e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.982425e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.982632e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.982865e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.983552e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.984499e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.984979e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.984979e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.985285e-01 | 0.001 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.986531e-01 | 0.001 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.986531e-01 | 0.001 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.990018e-01 | 0.000 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.990285e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.991325e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.991443e-01 | 0.000 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.991943e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.992579e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.993089e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.995314e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.995499e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.995499e-01 | 0.000 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.995649e-01 | 0.000 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.996880e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.997116e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.997722e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.997722e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.998053e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998097e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.998337e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.998686e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.998771e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.998897e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.998976e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999134e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999243e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999344e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999362e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999578e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999588e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999655e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999740e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999792e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999817e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999839e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999876e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999930e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999944e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999948e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999948e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999955e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999955e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999957e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999972e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999973e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999976e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999983e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999983e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999992e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999999e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |